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ABSTRACT 
 
Heme-copper respiratory oxygen reductases reduce O2 to water and use the redox 
free energy to generate the proton motive force. Among the heme-copper oxygen 
reductases are the quinol oxidases, which catalyze the 2-electron oxidation of ubiquinol 
or menaquinol instead of cytochrome c. Escherichia coli (E. coli) cytochrome bo3 is the 
best characterized quinol oxidase. Depending on the detergent used to solubilize the 
enzyme, cyt bo3, preparations of this enzyme contain between 0 to 2 equivalents of 
ubiquinone-8. Studies using ubiquinol-1, a soluble quinol substrate, indicate one high 
affinity quinone binding site, which acts as a non-exchanging co-factor, and a second, 
low-affinity site which is the substrate site. The residues interacting with the quinone at 
the high affinity QH site are well defined through numerous mutagenesis and 
spectroscopic studies, but the identification of the low affinity QL site has remained 
difficult.  
To clarify whether the low affinity QL exists, we used structural models to guide 
us. First is based on the new structure of cytochrome bo3 we have obtained by 
collaboration with the Stowell group. It shows two ubiquinone molecules bound to the 
enzyme. The benzoquinone headgroup of one bound quinone is located at the expected 
QH site. The headgroup of the second bound quinone is, however, located on the opposite 
side of the molecule. Site-directed mutagenesis of residues located at the putative second 
site do not indicate that this second site is functionally important, leaving the question of 
the existence of the QL site open. The second model is based on bioinformatics. Recent 
	   iii 
publication from Bossis group used bioinformatics methods to identify a possible QL site. 
We have tested this model using site-directed mutagenesis but have found no evidence 
for disruption of a substrate binding site. Along with these two models, we have revisited 
the possibility of a QL site in subunit II with site-directed mutagenesis but did not find the 
QL site. 
A strong argument in favor of the existence of the QL site is the inability of the 
quinone bound at the QH site to exchange during enzyme turnover. These experiment 
were performed using the soluble quinone analogue, ubiquinone-1. This experiment has 
been repeated with long chain quinol substrates to test the possibility that these might 
behave differently. If these long chain quinones exchange into the QH site during turnover, 
there would be no need to postulate the existence of the second QL site.    
All of the previous attempts to exchange the quinone at the QH were done in the 
purified micelles-form of enzyme with short chain quinone analogue, UQ1 or inhibitors. 
In my work, I will demonstrate that, in the lipid bilayer this “tightly bound” quinone can 
not only dissociate, but also can exchange with an exogenous quinone. Cyt bo3 embedded 
liposomes allowed us to reconstitute a respiratory chain using with a monotopic 
membrane protein, NDH-2, and have a good turnover with hydrophobic long chain UQ10. 
Moreover, we show that the “tightly-bound” quinone can readily exchange with UQ2 
even in micelles depending on incubation time and concentration of the substrate. 
Therefore, proving that this “cofactor-like” quinone can actually dissociate from the 
enzyme and exchange with exogenous quinone, allows us to argue that there is only one 
quinone binding site. 
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I. INTRODUCTION
1. Overview of the heme copper oxygen reductases
Heme-copper oxygen reductases (HCO) are terminal oxidases from aerobic 
respiratory chain (Fig. 1.1), membrane proteins catalyzing reduction of oxygen to water. 
The redox energy is coupled to proton translocation, which contributes to the 
electrochemical proton gradient that drives energy-requiring processes such as ATP-
synthesis. The protons are taken from the negative (N) side of the membrane and are 
released to the positive (P) side membrane through proton channels [1-8]. 
8𝐻!"! + 𝑂! + 4𝑒! → 4𝐻!"#! + 2𝐻!𝑂 
Among HCOs, subfamilies A, B and C are distinguished based on the phylogeny, 
genomic sequence, and structural information. Each of these subfamilies pumps protons 
coupled to reduction of oxygen. However, the proton pathways are different among the 
subfamilies. The sequence homology of the main subunits (I and II) among HCOs in the 
same subfamily show significant sequence similarity (>35% identity) while HCOs 
outside of the subfamily show much less sequence homology (<20% identity). This 
shows the large divergence among the subfamilies [6, 8, 9]. 
HCOs are also differentiated on the basis of the electron donor. If the electron 
donor is quinol, the oxidase is categorized as a quinol oxidase (e.g., cytochrome bo3 from 
Escherichia coli). If the of electron donor is a cytochrome c, the oxidase is categorized as 
a cytochrome c oxidase (CcO). The difference of electron donor correlates with structural 
differences. CcOs have a di-copper site (CuA) in subunit II, whereas the quinol oxidases 
have a quinol binding site instead within subunit I and do not have a CuA site [1, 8, 10]. 
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HCOs are found in all three domains of life [9]. The bovine heart mitochondrial 
cytochrome oxidase is among the most studied HCO, as is the bacterial CcO from 
Rhodobacter sphaeroides. Cytochrome (cyt) aa3 from R. sphaeroides is an A-family 
enzyme, which consists of four subunits. Subunits I, II and III are homologues of the 
equivalent subunits in the mitochondrial enzyme. Subunits I and II contain all that is 
required for catalytic function, including proton pumping. Subunit I is the largest (15 
transmembrane helices) and most conserved subunit. The redox active metals in subunit I 
are embedded within the membrane: the low spin heme a, the high spin heme a3 and CuB. 
Heme a3 and CuB form the binuclear center, which is considered to be the catalytic site. 
The copper is ligated to three conserved histidines. One of the histidine ligands is 
crosslinked to a tyrosine, which forms a novel His-Tyr crosslinked cofactor [4, 7, 10].  
2. The respiratory chain and quinones, in E. coli
Prokaryotes usually have a simplified respiratory chain. In the case of E. coli, the 
respiratory chain has a two NADH dehydrogenase (complex I and NDH2), succinate 
dehydrogenase, and three terminal oxidases (cyt bo3, bdI and bdII). Different organisms 
contain different quinone species as electron carriers. In case of E. coli, there are three 
types of quinones: ubiquinone (UQ8) is the main quinone for aerobic respiration while 
menaquinone (MK8) and demethylmenaquinone (DMK8) are the main quinones present 
during anoxic growth conditions. Once reduced, both UQ8 and MK8 quinones are 
ultimately oxidized by the respiratory quinol oxidase which reduces oxygen to water. 
Under conditions of high aeration, cyt bo3 is highly expressed and uses ubiquinol (UQ8) 
3 
as an electron donor while cyt bdI or bdII are expressed in other situations.  Both cyt bd 
enzymes have a high oxygen binding affinity and utilize menaquinol (MK8) as a substrate. 
Demethylmenaquinone is the main electron source under high nitrate respiration [6, 11-
13].  
The midpoint potentials the quinones are +0.11 mV, -0.08 mV, and +0.04 mV 
corresponding each to UQ8, MK8, and DMK8. The values are lower than oxygen (+0.82 
mV) and all these quinones are energetically suitable to serve as an electron donor for the 
terminal O2 reductases or for the 𝑁𝑂!! reductase. (+0.42 mV for nitrate reductase) E. coli 
has evolved a complex network of parallel electron transfer pathways, allowing the cells 
to adapt under different environments and also broadening the range of conditions for 
cells to live [11-14]. Not all of the dehydrogenases can readily couple to the terminal 
reductases and such combinations are restrictive [14]. Under different conditions in E. 
coli, where different types of quinones are deficient or not able to be expressed, other 
quinones are limited by their function and there is an overall decrease in efficiency [15]. 
3. The cytochrome bo3 ubiquinol oxidase from E. coli
Cytochrome bo3 is the HCO in E. coli. Cyt bo3 has two hemes, low spin heme b 
and high spin heme o3, with a copper-binding site, CuB. The binuclear site is composed of 
heme o3 and CuB where the dioxygen binds and reduced to water. Cytochrome bo3 is a 
well-known A-family oxidase, which has two proton pathways, the D-channel and K-
channel, that lead up to the binuclear center. (Fig 1.2) The D-pathway starts from residue 
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D135 and progresses via N124, T211, N142, Y61, T204, S145, T201, and T149 and ends 
at E286. The K-pathway contains S315, S299, K362, T359, and Y288 [7, 8].  
Structurally A-family HCOs are very similar but cytochrome bo3 is a quinol 
oxidase. It is missing the dinuclear CuA copper site in subunit II and also does not have a 
cytochrome c binding site. Since there is no cyotochrome c in the aerobically grown 
enzyme and it utilizes ubiquinol as an electron donor, the ubiquinone binding site was 
first thought to be in subunit II which is where the cytochrome c binds in the A-family 
enzymes that utilize cyt c as the electron donor [7, 8]. In 2000, Abramson et. al., obtained 
the crystal structure of cytochrome bo3. Using sequence homology and site-directed 
mutagenesis, they identified a likely ubiquinone binding site [8]. The ubiquinone is 
bound to the enzyme in subunit I, 13 Å far from low spin heme b. Residues R71, D75, 
H98, and Q101 are indicated as the high affinity site (QH). It is not clear whether two 
binding sites exist or just one, but in this study there was no second binding site (QL) to 
be indicated.  
Four protons per O2 are taken up for oxygen chemistry and four additional 
protons are pumped across the membrane. This cuases generation of an electrochemical 
gradient which drives ATP synthesis. Both structural analysis and site-directed 
mutagenesis have identified two conserved proton entry channels in the A-family HCOs: 
the D-channel and K-channel. These channels convey protons from the cytoplasm both 
for proton pumping and for chemistry at the active site (formation of H2O). The residues 
in each channel are conserved within the family. Proton transfer occurs through a series 
of internal water molecules, which provides a continuous sequence of hydrogen bonds. 
Mutagenesis studies have shown that the D-channel is used for the input of all pumped 
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protons (4 per O2) and provides two of the four protons required for chemistry of O2
reduction at the active site. Mutating the conserved residues at the beginning and end of 
the D-channel (D132 and E286 in the R. sphaeroides cyt aa3) eliminates catalytic 
function [16-19]. In contrast, mutating N139 to aspartate eliminates proton pumping 
without altering the catalytic rate. The K-channel in the A family HCOs, on the other 
hand, does not convey pumped protons, but delivers two chemical protons for the O2 
reduction [3, 20-23]. The redox chemistry catalyzed by the enzyme is coupled to proton 
pumping that generates proton motif force. Unlike protons which use specific pathways, 
water diffuses randomly out of the enzyme without any specific pathways [24]. 
4. Kinetics of electron and proton transfer
As mentioned above, the novel electron donor for cyt bo3 is UQ8. During the 
catalytic cycle, electrons are transferred to the active site in consecutive steps: QH →heme 
b→heme o3 [2]. The electron transfer rate  𝑘!" , as described by the semiclassical Marcus 
theory, is the reaction between the electron donor and acceptor at a fixed distance.  
𝑘!" = 2𝜋ħ 𝐻!" ! 14𝜋𝜆𝑘𝑇 𝑒𝑥𝑝 − ∆𝐺 + 𝜆!4𝜆𝑘𝑇
where ∆𝐺  is  the driving force of the reaction, 𝐻!"   is the electronic coupling between the 
donor and acceptor, and 𝜆  is the reorganization energy [25-27]. Intramolecular electron 
transfer rate between heme o3 and heme b rate (9 Å) is 1.1 ×  10!𝑠!! at 25 °C which is 
similar to cyt aa3 from R. sphaeroides (1.2 ×  10!𝑠!!) [26]. During the process of 
electron transfer from heme b to heme o3 the reaction is coupled to proton movement [28]. 
6 
5. Figures and tables
© 2015 David Goodsell & RCSB Protein Data Bank 
Fig. 1.1 Schematic representation of the E. coli respiratory chain and ATP synthase. 
7 
Fig. 1.2 The two proton pathways, D-channel and K- channel, in cyt bo3 from E. 
coli. As represented, each channel merges into the binuclear center. (1FFT.pdb) 
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II.  CHARACTERIZING THE DIFFUSION OF O2 IN TWO A-
FAMILY OXYGEN REDUCTASES: CYTOCHROME BO3 
FROM E. COLI AND CYTOCHROME AA3 FROM R. 
SPHAEROIDES  
1. Introduction 
It is critical for the substrate O2 to reach the active site for the enzyme to function. 
At room temperature, the oxygen solubility in water is about 250 uM. O2 has been shown 
to be concentrated 4~5 times higher in the biological membranes than in water [1]. This 
is presumably why the hydrophobic channel in the HCOs starts from the lipid bilayer and 
leads to the active site [2]. The oxygen pathway to reach the active site will be 
functionally important only under circumstances when the rate of O2 diffusing to the 
active site becomes rate limiting. Under steady state conditions, this will only occur when
2[O ] MK<< . Under these conditions, the enzyme reaction rate will depend on the product 
of the oxygen concentration, the enzyme concentration and the second order rate constant 
for the reaction. 
 1 2 1 2[O ][E]          or  [O ][E]
raterate k k= =  
The rate constant can be expressed in terms of the Michaelis-Menten parameters. 
 
1
1 1
1       units: cat
M
k sk s M
K M
−
− −= =  
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 Using this simple approach, we can ask under what conditions the second order rate 
constant, 1k , will be rate limiting. This condition implies that  
k1[O2]< kcat          or      [O2]<
kcat  
k1
	  
where	  kcat	  is	  determined	  by	  the	  rate	  of	  the	  slowest	  step	  in	  the	  chemistry	  that	  follows	  the	  binding	  of	  O2.	  For	  cyt	  bo3	  and	  cyt	  aa3	  this	  is	  about	  1000	  s-­‐1.	  
	  We	  can	  also	  write	  this	  as	  	  
[O2]<
kcat
k1
≈
1000
k1
 
This means that when the O2 concentration is lower than 
1
1000
k
 second order rate constant 
will limit the rate of catalysis. If it is important for the enzyme to react as fast as possible, 
even at low [O2], then one would expect the enzyme to have evolved to have the value of 
the second order rate constant 1k to be as large as possible [1]. For example, if k1 = 10
9M-
1s-1, then at concentrations of oxygen below 1 µ the rate of oxygen reaching the enzyme 
active site by diffusion will be rate limiting.  
The question addressed in the research project is whether the hydrophobic 
channel in subunit I of the E. coli cyt bo3 or R. sphaeroides cyt aa3 is a critical structure 
to facilitate rapid diffusion of [O2] to the enzyme active site. These enzymes are 
expressed under high oxygen condition; therefore the need for a special channel to 
facilitate diffusion of oxygen could be questionable. It has been suggested, but not 
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demonstrated, that the rate of O2 diffusion through the protein would be much slower in 
the absence of the specific pathway “designed” for this purpose [3, 4]. 
 
2. Structural information on the hydrophobic channels 
Employing gas pressurization and freeze-trap kinetics, Fee’s laboratory 
successfully solved X-ray structures of cyt ba3 (B-family) from Thermus thermophilus 
showing several binding sites of xenon [5] and krypton [6] along a hydrophobic channel 
that appears to be accessible to the catalytic site from the membrane [7, 8]. The binding 
of Xe and Kr has suggested the potential function of this particular channel as the 
putative O2 channel. Xe and Kr are good analogues of O2 because they are gases, which 
are soluble in non-polar environments and are also similar in size. The van der Waals 
diameters of O2 are ~4.2 Å (O-O bond), Xe (~4.3 Å) and Kr (~4.0 Å).  
Other enzymes have been shown to favor O2 pathway. Hydrophobic pathways 
have been identified in the following proteins: cholesterol oxidase, copper amine oxidase, 
hemoglobin, and more [9-15]. Copper amine oxidase (CuAO) from E.coli structure used 
Xe to probe the putative oxygen-entry pathway. It is common to use Xe for mapping the 
pathway from crystallography and use site-directed mutagenesis method to confirm this 
oxygen pathway [7, 8, 11]. 
Xe binding sites in cyt ba3 structures form a bifurcated Y shaped channel with 
two entry point, converges directly to the catalytic site. This hydrophobic channel is also 
found in X-ray structures of A-family CcOs from R. sphaeroides, P. dentrificans, and 
Bovine heart. As opposed to B-family from T. thermophilus cyt ba3, A-family CcOs 
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exhibit only one entrance into the channel [7, 8]. Superimposing the hydrophobic 
channels on top, one can obtain a secondary structure-based sequence alignment. This 
well conserved feature, allows us to measure the O2 binding rate. Cyt ba3, which has the 
second order O2 binding rate of 1  ×  109 M-1s-1, is 10 fold faster than bovine aa3 or R. 
sphaeroides cyt aa3 [16, 17]. With site directed mutagenesis, we can increase the 
hydrophobic area in the cyt bo3/aa3 to see if it can increase the binding rate to that of 
bring it up as cyt ba3.  
	  
3. Cytochrome bo3 from E. coli [18]  
1. Methods 
Site-directed mutagenesis  
pET cyo is a pET-17b derived plasmid, with T7 promoter and encodes the operon 
cyoABCDE including histidine tag at the C-terminus of subunit II and has Ampicillin 
antibiotic resistance (constructed by previous group member, Lailai Yap). All 
oligonucleotides were ordered from IDT (Integrated DNA technologies). (Table 2.1) PCR 
was used to perform site-directed mutagenesis using Agilent (Santa Clara, CA) kit. 
PfuUltra High-Fidelity DNA Polymerase was used to lower the error rate. Dpn1 was used 
to digest the template for at least 4 hours of incubation at 37 °C. After using PCR 
purification, using GeneJET™ Kit (Thermo Scientific,	  Bannockburn, IL), the plasmids 
were transformed into XL10-Gold ultracompetent cells (Agilent). This was later spread 
onto Ampicillin plate and incubated at 37 °C overnight. 
Colonies that were picked and grown in LB media were later spun down and the 
plasmids were extracted using GeneJET™ Plasmid Miniprep Kit (Thermo Scientific,	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Bannockburn, IL). The sequence verification of mutagenesis products was performed at 
the University of Illinois Urbana-Champaign (UIUC) Biotechnology Center. All 
chemicals of the purest grade available were used. 
E. coli C43 (DE3) (Avidis, France) strains were used for expression of membrane 
proteins [19]. CLY strain is a derivative of C43 (DE3) strain, that has bo3 knockout 
replaced by a Kanamycin resistance factor cassette, was used for this purpose. After 
transforming the mutated plasmids into CLY competent cells and grown in 5 ml of LB, 
the cells were centrifuged and went through miniprep for another sequence verification at 
the same facility. A 500 𝜇𝑙  aliquot of the cells was used to make a frozen glycerol stock 
(final concentration of glycerol 25%, stored in -80 °C freezer). 
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Name Primer sequences 
W170Ffor CGC AGA CCG GCT TTC TGG CCT ATC C 
W170Frev GGA TAG GCC AGA AAG CCG GTC TGC G 
W170Yfor GCA GAC CGG CTA TCT GGC CTA TC 
W170Yrev GAT AGG CCA GAT AGC CGG TCT GC 
V108Ffor CCG CGC ACG GCG CGA TTA TGA TCT TC 
V108Frev GAA GAT CAT AAT CGC GCC GTG CGC GG 
L246Ffor CCT TCC CAA TTT TCA CGG TTA CCG TC 
L246Frev GAC GGT AAC CGT GAA AAT TGG GAA GG 
W282Tfor GAT TTG GGC CAC GGG CCA CCC GGA AG 
W282Trev CTT CCG GGT GGC CCG TGG CCC AAA TC 
F112Ifor CGT GAT TAT GAT CAT CTT CGT AGC GAT GCC 
F112Irev GGC ATC GCT ACG AAG ATG ATC ATA ATC ACG 
I111Mfor CAC GGC GTG ATT ATG ATG TTC TTC GTA GC 
I111Mrev GCT ACG AAG AAC ATC ATA ATC ACG CCG TG 
 
Table 2.1 List of primers used in the Site-directed mutagenesis. 
 
Cell growth and purification  
Cells were inoculated from the glycerol stock, with antibiotics (Ampicillin 100 𝜇𝑔/𝑚𝐿, Kanamycin 50 𝜇𝑔/𝑚𝐿) and grown in LB media at 37 °C, 210 rpm which later 
was transformed into a pre-inoculum of minimal media (M63) with Thiamine 
(10  𝜇𝑔/𝑚𝐿), CuSO4 (1 𝜇𝑀), MgSO4 (1 𝜇𝑀), and glucose (2 𝑔/L). Minimal medium was 
autoclaved prior to adding additional vitamins. This pre-inoculum was grown overnight, 
and was used for a larger growth the next day. After reaching OD600 of 0.6, the cells were 
induced with IPTG (0.5 𝑚𝑀) and left to grow for 4~5 hours more. The cells were 
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harvested by centrifugation at 8,000 rpm at 4 °C for 10 minutes per run in a Sorvall GS3 
rotor and the supernatant was discarded and the pellets were collected. The cell pellets 
were resuspended in 50 mM KPi at pH 8.3 and MgSO4 was added along with Protease 
Inhibitor Cocktail (Sigma, Saint Louis, MO), and Deoxyribonuclease I from bovine 
pancreas (Sigma). This was gently shaken it to mix it well. The cells were broken by a 
microfluidizer (Microfuildics Corp. Waltham, MA), filled with ice around the device to 
keep the temperature down. The cell lysates were centrifuged at 8,000 rpm for 15 min at 
4 °C to remove the cell debris. The membranes were isolated from the supernatant after 4 
hours centrifugation at 40,000 rpm, 4 °C in a Beckman Ti45 rotor. At this point the 
membranes could be stored at -80 °C freezer for later use. The isolated membranes were 
resuspended in 50 mM Kpi, pH 8.3 buffer with final concentration of 1 % dodecyl 
maltoside (DDM) detergent (Anatrace, Maumee, OH) by stirring at 4 ° C. The 
unsolubilized material was removed by centrifugation at 42,000 rpm for 45 min at 4 °C 
temperature using the Beckman Ti45 rotor. The supernatant that contained the solubilized 
protein was incubated with nickel-nitrilotriacetic acid (Ni-NTA) resin with 5 mM 
imidazole for ~1 hour with gentle stirring in the cold room (4 °C). Everything from this 
point was done in the cold room. After an hour, the Ni-NTA resin with the protein bound 
was loaded onto the column and washed with 50 mM KPi, pH 8.3, 0.05% DDM, 10 mM 
imidazole buffer with 10 column-volumes of Ni-NTA resin. After that, the column was 
washed with 5 volumes of 50 mM KPi, pH 8.3, 0.05% DDM, 15 mM imidazole buffer. 
Finally the enzyme was eluted with 50 mM KPi, pH 8.3, 0.05% DDM, ~150 mM 
imidazole buffer. The eluted protein was concentrated using a 100-kDa cutoff Amicon 
(Millipore), followed by buffer exchange into 50 mM KPi, pH 8.3, 0.05% DDM buffer, a 
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total of three times. The protein with 5% glycerol was flash-frozen in liquid nitrogen and 
stored at -80  °C for future use. 
 
Traditional CO flow-flash 
The traditional way to do the photolysis experiment with HCOs is to first bind the 
reduced HCO to carbon monoxide [20-23]. In a stopped flow, the CO-enzyme adduct is 
mixed with a solution with about 1 mM O2. Within a few seconds, a laser flash ejects the 
CO from the enzyme active site and allows O2 to bind [8, 11, 21, 23, 24]. In the cases of 
cyt bo3 and cyt aa3 the Einarsdottir group has shown that caged O2 and caged NO show 
the same O2 rate of binding (data not shown). Therefore, the caged substrate method was 
not used.   
The reduced enzymes (used ascorbic acid and ruthenium hexamine) were 
incubated with CO to make sure it was fully reduced and CO-bound (incubation for 30 - 
60 min). The fully reduced, CO-bound enzyme was mixed 1:1 volume ratio with O2 or 
NO- saturated buffer, followed by photolysis to release CO from the heme o3 using a Q-
switched DCR-11 Nd:Yag laser (532 nm) [16, 17]. 
The data obtained were analyzed using single value decomposition (SVD) and 
global exponential fitting using programs from Matlab.  
 
CO Flash-Photolysis 
The experiment is similar to the flow-flash method, but instead of mixing, the 
photolysis solution remains in an anaerobic quartz-cuvette. The sample was reduced with 
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ascorbate and ruthenium hexamine or dithionite. After reducing the enzyme, the samples 
were exposed to CO for 15 minutes to form reduced, CO-bound enzyme complex. The 
CO recombination rate was measured by photolysis of the reduced, CO-bound enzyme 
using the time-resolved optical absorption spectroscopy [25]. The photolysis used the 
same laser as for the flow-flash experiment. All spectra were analyzed using SVD and 
global exponential fitting using Matlab.    
 
2. Results 
The O2 binding rates to different HCOs have been previously measured [8, 11, 16, 
17, 21, 24, 26, 27]. However, in the case of cyt bo3, the enzyme preparations contained a 
substantial impurity with heme o replacing heme b in the low spin site, yielding cyt oo3 
[28-30]. With the improvement of expression strains optimized for membrane protein 
expression and using a system using the T7 promoter, the improved cytochrome bo3 has 
the expected 1:1 ratio of heme b : o which is essential to get accurate measurements. 
The flow-flash experiment reveals the rate constant for the initial O2 binding as 
well as the subsequent electron transfer and proton uptake rates.  This is all monitored by 
following the changes in the heme absorption. Whereas the cytochrome c oxidases use a 
1-electron donor, cyt bo3 uses a 2-electron donor, ubiquinol. Cyt bo3 has a ubiquinone 
bound to its QH site after purification using DDM. The flow-flash experiment follows one 
turnover of the fully reduced enzyme as it interacts with O2.  Starting from fully reduced, 
CO-bound enzyme, following photolysis, the full optical absorption spectra were 
recorded as a function of time (Fig 2.1). In addition to the studies using O2, NO was also 
used as a substrate analogue which does not have subsequent redox chemistry following 
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the initial binding to the active-site heme. This provides an alternate measure of the initial 
rate of ligand binding. The first spectrum is obtained after a 1 𝜇𝑠 delay and the last at 20 𝑚𝑠 following photolysis.  
 
Fig 2.1 The full optical absorbance difference spectra of WT cyt bo3 recorded at 
different times after photolysis 500 ns – 20 ms. 
 
The previous analysis of the rates obtained with the aa3-type bovine cytochrome c 
oxidase, was used as point of comparison. However, the initial fully reduced cytochrome 
c oxidase enzyme contains 4 reducing equivalents, just enough to reduce O2 to 2 H2O, 
whereas the fully reduce quinol oxidase contains 5 reducing equivalents since the 1-
electron reduced CuA is replaced by the 2-electron reduced ubiquinol.  Hence, there is an 
“extra” electron left over after one turnover.  
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After obtaining the spectra and doing the SVD analysis and global exponential 
fitting, the time-resolved spectra were analyzed assuming a kinetic model with five 
sequential steps with characteristic times of 42  𝜇𝑠, 22 𝜇𝑠, 30  𝜇𝑠, 470 𝜇𝑠  and 2.0  𝑚𝑠. The 
spectroscopic changes with each step were analyzed by comparison to the independently 
obtained spectra of different oxygenated forms of the enzyme. Our results differ from the 
conventional sequential mechanism of O2 reduction. The conventional mechanism is a 
linear series of sequential steps with progressively slower rate constants from R → A → P →  F → O. In our case, comparing the spectra of each step, we observed that the first step 
R → A takes 42 𝜇𝑠 but that the following step rapidly converts A to a combination state 
of P and F with a characteristic time of 22  𝜇𝑠. Hence this is called the “slow-fast” 
mechanism.  The short lifetime of the A intermediate state would result from a fast proton 
transfer leading to a mixture of P and F. In 30 𝜇𝑠 the complete F intermediate state is 
formed by partial reduction of heme b by the bound quinol (forming a semiquinone). The 
oxoferryl heme o3 intermediate in the F state is reduced to the ferric hydroxyl form by an 
electron from the quinol/semiquinone in 470 𝜇𝑠 without further oxidation of the ferrous 
heme b. This state corresponds to the O state found in cytochrome c oxidase, but differs 
due to the presence of one “extra” electron (shared between heme b and the bound 
ubiquinone) and is therefore called the O1 state. The final 2 𝑚𝑠 transition is not well 
defined and may involve reaction with a second ubiquinol molecule, where the reduced 
heme b becomes oxidized and this electron reduces the heme o3.  
By this kinetic analysis, the second order binding constant of O2 to cyt bo3 is 3.8 ×  107 M-1s-1. This is 25-fold slower than T. thermophilus cyt ba3 and 2.5-fold slower than 
bovine cyt aa3 or R. sphaeroides cyt aa3 [16, 17]. Site-directed mutagenesis was 
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performed on residues that appear to form a constriction in cyt bo3 within the putative O2 
channel (in comparison to cyt ba3, where the rate constant is 25-fold greater) in an effort 
to increase the diffusion of O2 to the active site of cyt bo3 (Table 2.2, bold, italic) [31]. 
 
Enzyme species Constriction point Hydrophobic branch
1  
R. sphaeroides aa3 F282 W172 M107 F108 I104  
E. coli bo3 W282 W170 I111 F112 V108  
  
 Table 2.2 Structure and sequence homology. Four cytochrome c oxidases were 
selected for comparison [7]. There are several hydrophobic branches but here only one 
was selected. The hydrophobic branches converge to the constriction point where a single 
pathway leads to the binuclear center.  
 
Five different mutants were examined by flow-flash and the results are 
summarized in Table 2.3, with the time-resolved difference spectra shown in Figures 2.2, 
2.3 and 2.4. The results are in each case similar to those of the wild type, indicating no 
substantial change in the rate constant for O2 binding to the active site due to these 
mutations. 
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Figure 2.2 b-spectra (A, C) for a two-exponential fit of the TROA difference 
spectra recorded for the reaction of the photo-produced O2 with the fully reduced I111M 
and F112I E. coli bo3 mutants, respectively. The b0 is the difference between time zero 
and the last time point recorded, and represents the difference spectra extrapolated to 
infinite time.  
 
	  
 
Figure 2.3 b-spectra (A, C) for a two-exponential fit of the TROA difference 
spectra recorded for the reaction of the photoproduced O2 with the fully reduced W282T 
and W170Y E. coli bo3 mutants, respectively.  
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Figure 2.4 (A) TROA difference spectra (post-minus-pre-photolysis) of the 
reaction of the fully reduced V108F E. coli bo3 enzyme with photo-produced O2 in the 
absence of CO. The Soret and visible spectra were recorded together at logarithmically 
spaced time delays of 2 µs - 50 ms. (B) b-spectra resulting from a two-exponential fit.  
 
Table 2.3 The apparent lifetimes and second-order rate constants for O2 binding 
in cyt bo3 constriction point and hydrophobic pocket mutants. The factor increase is 
versus wild-type (WT) enzyme. 
Mutants tau (𝝉) O2 concentration 2nd order rate constant Increase folds  
WT 500 𝜇𝑠 54 𝜇𝑀 3.7 × 10!  𝑀!!𝑠!! -  
V108F 616 𝜇𝑠 50 𝜇𝑀 3.3  × 10!  𝑀!!𝑠!! 0.87  
I111M 1.15 𝑚𝑠 39  𝜇𝑀 2.2 × 10!  𝑀!!𝑠!! 0.59  
F112I 527  𝜇𝑠 36  𝜇𝑀 5.3  × 10!  𝑀!!𝑠!! 1.4  
W173Y 431 𝜇𝑠 50 𝜇𝑀 4.6 × 10!  𝑀!!𝑠!! 1.2  
W282T 418 𝜇𝑠 43  𝜇𝑀 5.6 × 10!  𝑀!!𝑠!! 0.69  
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3. Discussion and conclusions 
As mentioned earlier, cytochrome bo3 has not been studied thoroughly due to 
previous issues with the heme content of recombinant enzyme. With the new strain 
provided by previous lab member, and using minimal medium (M63) instead of LB, it is 
possible to get the heme b : o ratio to 1:1, which was not possible before. Once that was 
possible, using the flow-flash measurement, we were able to measure the second order O2 
binding rate and moreover, were able to see the mechanism of O2 reduction in cyt bo3. 
[18] 
The O2 binding rate is slower than other A-family oxidases by about 3-fold and 
slower than the B-family oxidase cyt ba3 by 25-fold. The mutants that we made to 
increase the binding rate resulted in at most an increased up to two-folds. It is likely that 
cyt bo3 contains more than one pathway for O2 to reach the active site and therefore, a 
single mutation does not have much of an impact. It has previously been shown that the 
mutation of residues close to the active site can have a very large effect on the rate of 
reaction with O2 [32-34].   
To reduce O2 to H2O, four electrons are required. In cytochrome c oxidases, cyt c 
is the electron donor for the chemical reaction. Cyt bo3, which is an ubiquinol oxidase, 
uses ubiquinol (UQ8) as an electron donor. While cyt c carries only one electron, 
ubiquinol carries two electrons. The reduced form ubiquinol (UQH2) donates electrons 
sequentially one at a time, turning into ubisemiquinone, than to ubiquinone (UQ). 
Because of this extra (fifth) electron there are changes in the sequence of intermediates 
formed during the single turnover of O2 with the fully reduced enzyme. Previous 
measurements were not able to detect the initial complex of heme o3 bound to O2, the A 
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intermediate state [26]. In our experiments this state is observed and the second order rate 
constant for its formation is 3.8 ×   107 M-1s-1, which is 25-fold slower than T. 
thermophilus cyt ba3 and 2.5-fold slower than bovine cyt aa3 or R. sphaeroides cyt aa3 
[16, 17]. 
The first state observed following A in the flow-flash experiment is a mixture 
containing both states P and F, and is mostly F. These states are distinguished by a 
protonation of a group at the active site.  The P state in cyt bo3 can be observed by 
reacting the oxidized enzyme with H2O2 [35], but is very unstable as an intermediate in 
the reaction of O2 with the reduced enzyme, decaying to F very rapidly. The very short 
lifetime of P state must be due to very fast proton transfer, leading into an instant 
conversion of P to F state, so the pure P state is not observed.  
The other main difference between the flow-flash results with cyt bo3 and 
previous results with cyt c oxidases is the complications due to the bound 2-electron 
reduced quinone in the cyt bo3 as well as the presence of some additional reduced 
quinone in the preparation.  This results in formation of an O1 state that has an extra 
reducing equivalent present, shared between the quinone and heme b, and a slow reaction 
that appears to be due to subsequent reduction by some contaminating ubiquinol.  
Site-directed mutagenesis was performed to increase the O2 second order binding 
rate. However, as the flow-flash results show, the binding rate constant increased by at 
most two-fold. The very rapid rate constant for the B-family cyt ba3 is likely the result of 
evolution under the stress of growth conditions with very low oxygen concentration. It is 
also likely that cyt bo3 contains more than one pathway for O2 to reach the active site and 
therefore, a single mutation does not have much of an impact. It has previously been 
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shown that the mutation of residues close to the active site can have a very large effect on 
the rate of reaction with O2 [32-34].   
 
4. Cytochrome aa3 from R. sphaeroides 
1. Methods 
 Site-directed mutagenesis  
The Quik-Change mutagenesis kit was used to introduce mutations. Plasmid 
pUC19 (Ampicillin 100  𝜇𝑔/𝑚𝑙) was used as the template for mutations (only encodes 
subunit I) and the sequence verification of mutagenesis products was performed at the 
University of Illinois Urbana-Champaign (UIUC) Biotechnology Center. (Table 2.4) All 
chemicals of the purest grade available were used. After verification of the mutations, the 
cyt aa3 gene was digested and ligated into pRK415 using Quick Ligation™ Kit (New 
England BioLabs,	   Ipswich, MA). After ligation, the expression plasmid pRK-415 
(tetracyclin, 15 𝜇𝑔/𝑚𝑙) was introduced into R. sphaeroides JS100 strain by biparental 
conjugation using E. coli S-17-1 as a donor. (JS100 has a subunit I replacement in the 
genome with a streptomycin/spectinomycin resistance cassette.) All the E. coli cells were 
grown at 37 °C. All of the R. sphaeroides cells were grown at 30 °C, at 210 rpm using  
2L flasks, each with only 800 ml of Sistrom’s medium to maintain high aeration.) After 
each step of transformations the sequence of the plasmids were verified. 
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Name Primer sequences 
W172Yfor GGC ATC GGC TAT GTG CTC TAT CCG 
W172Yrev CGG ATA GAG CAC ATA GCC GAT GCC 
F282Tfor GCA CAT CCT GTG GTT CAC CGG CCA CCC 
F282Trev GGG TGG CCG GTG AAC CAC AGG ATG TGC 
 
Table 2.4 List of primers used in the site-directed mutagenesis. 
 
2. Results 
As mentioned before, the cyt aa3 has an O2 binding rate constant of 1×  108 M-1s-1. 
This is 10-fold slower than T. thermophilus ba3. From the Stout group’s structural 
comparison, the hydrophobic cavity volume is smaller than cyt ba3 [7]. Comparing cyt 
aa3 to cyt ba3 hydrophobic pathways, cyt ba3 has two separate pathways converging to 
the binuclear center from the membrane, while aa3 has only one pathway. We attempted 
to expand the pathway by site-directed mutagenesis to increase the binding rate constant. 
Designing the pathway to become larger, the main target we focused on was to change 
the residues that appear to form a constriction point or a bottleneck to diffusion of oxygen.  
This was determined by comparison with the pathway in the R. sphaeroides cyt aa3 with 
that in cyt ba3.  The putative constriction point in the R. sphaeroides cyt aa3 corresponds 
to where the two pathways converge in cyt ba3. The residues at this location are W172 
and F282  (Fig 2.5).   
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Fig 2.5 Cyt aa3 active site with W282 and F172 residues that form the 
constriction point. The dark area indicated by the arrow is the hydrophobic pocket.   
 
 
Fig 2.6 UV/Vis spectra of WY/FT double mutant. The lowest intensity (black) is 
the oxidized spectrum with peak at 415 nm, the highest intensity (blue) is the dithionite 
reduced CO-bound enzyme with peak at 426 nm and the spectrum on the far right (red) is 
the dithionite reduced spectrum with peak at 435 nm. 
 
F282 
W172 
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Residue W172 was mutated to tyrosine and F282 was mutated to threonine. The 
double mutant has a perturbed spectrum (Fig 2.6), and the expression yield of the enzyme, 
compared to the WT was low.  Due to the low amount of available mutant enzyme, we 
could not perform the flow-flash to obtain the O2 second order-binding rate. We did 
measure the CO recombination of the mutant and these data were compared to those from 
the WT enzyme.  
The enzymes were maintained under anaerobic conditions to assure full reduction 
by either ascorbic acid/ruthenium hexamine or dithionite. After fully reducing the 
enzyme, CO was added for 15 minutes to form the reduced CO-bound enzyme complexes. 
The CO ligand was photolyzed by 532 nm laser flash and the spectroscopic changes were 
determined on a 200 𝑛𝑠 - 500 𝑚𝑠 time scales. The difference spectra were analyzed using 
SVD and global exponential fitting. (Fig 2.7) 
The peak and the trough of the double mutants (W172YY/F282T) have both 
shifted and became broader compared to the WT. The time-resolved spectral changes 
were analyzed using a four exponential fit for the WT with characteristic times of 0.9 𝜇𝑠, 
54  𝜇𝑠, 500 𝜇𝑠, and 23 𝑚𝑠. (Fig 2.7) In the meantime, the W172YY/F282T spectral 
analysis was satisfied by a three exponential fit with characteristic times of 0.6 𝜇𝑠, 44 𝜇𝑠, 
and 300 𝜇𝑠. Fig 2.8 shows the comparison of b-spectra of the first three lifetimes. The b-
spectra of W172YY/F282T have been blue shifted ~5 nm to match those of the WT. The 
process corresponding to the highest amplitude b-spectrum is the CO recombination to 
heme a3. This recombination time for the WT is 23 𝑚𝑠 but for the W172YY/F282T 
mutant, the recombination time is 44 𝜇𝑠, 500 times faster.  
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Fig 2.7 Time-resolved optical absorption difference spectra (post minus pre-
photolysis) recorded following flash-photolysis of (a) the fully reduced CO-bound the 
wild-type fully reduced CO-bound cyt aa3 and (b) the W172Y/F282T R. sphaeroides cyt 
aa3. 
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Fig. 2.8 Comparison of the first three b - spectra of the wild-type R. sphaeroides 
aa3 (blue curves, 4-exponential fit) and W172Y/F282T (green curves, 3-exponential fit).  
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3. Discussion and conclusions 
From previous measurements we know cyt aa3 has an O2 binding rate constant of 
1×  108 M-1s-1. A double mutant, W172Y/F282T, was made in an attempt to reduce a 
bottleneck in the hydrophobic channel leading to the active site.  Due to the poor yield of 
the protein, only CO-recombination was studied to observe the influence of these 
mutations compared to the WT.  
The double mutant could not be completely reduced using ascorbate and 
ruthenium hexamine. The mutations clearly altered the structure of the cyt aa3 (Fig 2.6) 
as determined by the altered absorption spectrum. One of the double mutant residue, 
W172 is very close to the low spin heme a so it is plausible that the W172Y mutation 
might result in perturbations leading to different conformers as well as a change in the 
reduction potential [36]. The main effect is a 500-fold faster rate of CO recombination.  
This is most likely to result from the mutations preventing the exit of CO from the 
enzyme following photolysis. A similar “caged” active site has been observed previously 
by a mutation that is much closer to the active site of the heme [37]. Further studies are 
needed to clarify this situation. 
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III. BIOPHYSICAL STUDY TO ELUCIDATE THE LOW AFFINITY 
UBIQUINONE BINDING SITE (QL)  
1. Introduction 
Heme-copper oxidases (HCO) reduce O2 to water and use the redox free energy to 
generate proton motive force. The HCOs are categorized depending on the electron donor 
as to cytochrome c oxidases or quinol oxidases. Cyt bo3 from E. coli is the most studied 
ubiquinol oxidase along with menaquinol oxidase aa3-600 from Bacillus subtilis. In 2000 
the Wikström group published the structure of the cyt bo3 with four subunits, two low 
spin hemes and a CuB site (1FFT.pdb) [1]. However, this structure is missing a 
substantial part of the protein as well as the natural substrate ubiquinol-8 (UQ8). The 
study was used to successfully locate the QH site based on sequence analysis and site-
directed mutagenesis, but has not identified the QL site. 
There has been a question as to whether cyt bo3 has two ubiquinone binding sites 
or one binding site. A recent study from our group has concluded that there are two 
ubiquinone binding sites using inhibition (HQNO, AC-10) measurements (The inhibitor 
could not replace the bound ubiquinone.) [2-4]. However, the exact location of the QL site 
could not be identified. In this chapter, we show attempts to locate the QL site using site-
directed mutagenesis based on the new structure provided by Dr. Michael Stowell (Univ. 
of Colorado, Boulder) (unpublished). The mutagenesis was guided by suggestions from 
the analysis of the new structure, from knowledge of conserved residues that might 
conceivably participate in hydrogen bonding to quinone and from a bioinformatics study 
predicting the location of the QL site from the work of Bossis et al. [5]. The expectation is 
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that mutations that perturb the QL site will either lower the activity (or Vmax) or alter the 
KM for ubiquinol, so these parameters were measured [5]. 
 
2. The new structure, and the search for the low affinity 
ubiquinone binding site 
The cyt bo3 structure previously published [1] is incomplete and the resolution is 
poor (3.5  Å). This structure includes two low spin hemes and a CuB site but is missing 
many residues and substrate UQ8 [1]. The study located the QH site based on the location 
of a set of conserved residues that were thought likely binding partners to ubiquinone, 
however the QL site was not identified. Due to the missing residues and the substrate UQ8 
in the published structure of cyt bo3 many questions remain unanswered. The new 
structure provided by Dr. Stowell is an improvement and contains what appear to be two 
bound quinone molecules. In this chapter we will show a new structure and describe 
experiments to test the proposed QL site by directed mutagenesis. 
 
3. Methods  
Site-directed mutagenesis  
The same methods were used as Chapter 2. All oligonucleotides were ordered 
from IDT (Integrated DNA technologies). (Table 3.1) PCR was used for site-directed 
mutagenesis using Agilent (Santa Clara, CA) kit. The sequence verification of 
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mutagenesis products was performed at University of Illinois Urbana-Champaign (UIUC) 
Biotechnology Center. All chemicals of the purist grade available were used. 
 
Steady state enzymatic activity assay 
The steady state oxygen reduction activity of cyt bo3 was measured at 25  °C using 
YSI model 53 oxygen electrode (Yellow Springs Instrument Co., Yellow Springs, OH) 
that has an oxygen electrode chamber of 1.8 mL. The temperature is achieved using a 
water bath hooked up to the chamber. The reaction mixture was made using 50 mM Kpi, 
pH 7.0, 0.05% DDM with 2 mM dithiotherol and ~300 uM ubiquinone-1 (Q1, Sigma, 
Saint Louis, MO) with constant stirring. The oxygen saturated buffer at 25 °C is 
estimated to have an oxygen concentration around 250 𝜇𝑀. With all substrates added, the 
reaction is initiated as soon as ~4 𝑝𝑀 amount of enzyme is added into the mix. Turnover 
number (𝑒!!/sec/enzyme) of the enzyme is calculated based on the consumption of 
oxygen slope and subtracting the background slope prior to the addition of the enzyme. 
The kcat and KM values were determined by measuring the turnover number as a function 
of the ubiquinol-1 concentration over a range 1 𝑢𝑀 to 330 𝑢𝑀, and fitting the data to the 
Michaelis-Menten equation (below).  
 𝑉! =    𝑉!"#[𝑆]𝐾! + [𝑆] 
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Name Primer sequences 
W156Afor GGT CTT ATC TGG AGC CGG TGC TG 
W156Arev CAG CAC CGG CTC CAG ATA AGA AC 
R176Afor GCA CTA ACC GTA CCG CCA TCA TGT G 
R176Arev CAC ATG ATG GCG GTA CGG TTA GTG C 
Q195Ifor GAT TAC TGG ATA TGG AGT CTC ATC CTA TCC GGT ATA GGT ACG AC 
Q195Irev GTC GTA CCT ATA CCG GAT AGG ATG AGA CTC CAT ATC CAG TAA TC 
Q195Efor GGA TAT GGA GTC TCG AAC TAT CCG GTA TAG G 
Q195Erev CCT ATA CCG GAT AGT TCG AGA CTC CAT ATC C 
Q195Afor GGA TAT GGA GTC TCG CGC TAT CCG GTA TAG 
Q195Arev CTA TAC CGG ATA GCG CGA GAC TCC ATA TCC 
Q195Lfor GGA TAT GGA GTC TCC TGC TAT CCG GTA TAG 
Q195Lrev CTA TAC CGG ATA GCA GGA GAC TCC ATA TCC 
T247Vfor GCT TCC TTC CCA ATT CTG GTG GTT ACC GTC GCG TTG TTG AC 
T247Vrev GTC AAC AAC GCG ACG GTA ACC ACC AGA ATT GGG AAG GAA GC 
K25L(III)for CCA GGA TGC AGG CGG AAC CTT AAT CTT CGG ATT TTG GAT CTA CC 
K25L(III)rev GGT AGA TCC AAA ATC CGA AGA TTA AGG TTC CGC CTG CAT CGT GG 
G28V(III)for GGA ACC AAA ATC TTC GTG TTT TGG 
G28V(III)rev CCA AAA CAC GAA GAT TTT GGT TCC 
F29I(III)for CCA AAA TCT TCG GAA TTT GGA TCT ACC 
F29I(III)rev GGT AGA TCC AAA TTC CGA AGA TTT TGG 
Y32F(III)for CGG ATT TTG GAT CTT CCT GAT GAG C 
Y32F(III)rev GCT CAT CAG GAA GAT CCA AAA TCC G 
D36V(III)rev GAT TTT GGA TCT ACC TGA TGA GCG TGT GCA TTC TGT TCT CTA TC 
D36V(III)for GAT AGA GAA CAG AAT GCA CAC GCT CAT CAG GTA GAT CCA AAA TC 
D36N(III)for GAT TTT GGA TCT ACC TGA TGA GCA ACT GCA TTC TGT TCT CTA TC 
D36N(III)rev GAT AGA GAA CAG AAT GCA GTT CGT CAT CAG GTA GAT CCA AAA TC 
 
Table 3.1 List of primers used in the Site-directed mutagenesis. 
 
 44 
4. Results  
Native cytochrome bo3 from E. coli was purified and crystallized in nonyl-
glucoside and the structure determined using X-ray crystallography by the collaborator’s 
lab. Phase improvement was achieved through multiple rounds of model building, density 
modification, and refinement. The new structure resolved some of the issues, adding most 
of the missing residues and in addition has two ubiquinones bound to the enzyme. The 
final model contains 659 out of 663 residues of subunit 1, 306 out of 315 residues of 
Subunit 2, 203 out of 203 residues of Subunit 3, 109 out of 109 residues of Subunit 4. 
The Rcryst and Rfree are 0.374 and 0.446 at 3.8 Å with good stereochemistry and MOLPRO 
statistics, Fig. 3.1. 
The complete four-subunit enzyme adopts a dimeric quaternary structure, 
facilitated by a large dimer interface, and a long amphipathic helix, which wraps around 
the adjacent monomer. Two bound ubiquinones per monomer are observed on opposite 
sides of the putative membrane boundary. The position of the first ubiquinone (QH) is 
similar to that previously modeled and confirmed by mutagenesis and is located near the 
periplasm as predicted [1, 2, 6-8]. The second ubiquinone (head group especially) is 
located near the cytoplasm at a water channel. (Fig. 3.1) The second bound quinone 
should define the QL site but, as shown below, this proved not to be the case. 
To determine if the observed QL binding site is functional we performed site 
directed mutagenesis of potentially important residues based upon the new structure. (Fig. 
3.2) Table 3.2 lists the mutated residues and the relative activity of each compared to that 
of wild type (WT). The data show that each mutant exhibits near the same activity as the 
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WT. For each mutant, the KM of ubiquinol-1 was determined to see if any mutant 
perturbed this parameter, which might be expected if the off-rate constant of the substrate 
were increased. (Table 3.3)  The mutants show no or little increase in KM and not much of 
a change in the relative activities. The data strongly suggest that this site is not the 
ubiquinol-1 substrate binding site, QL. 
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Fig 3.1 Overall structure and comparison to previous reported structure. A) 
Observed dimer structure. B) Comparison of the current structure to the previously 
reported structure showing the newly observed residues. C) Side view of cyt bo3 with the 
ubiquinones bound to the enzyme at QH and QL site. (yellow) D) The red residues 
indicate the known QH site residues, and the ubiquinone is bound nearby those residues. 
The QL site ubiquinone is bound perpendicular to the QH site ubiquinone. The head group 
is facing the cytoplasm. 
C) Side view with substrate UQ8 bound D) The QH and QL site focused 
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Fig 3.2 Residues around QL site for site-directed mutagenesis. Black TM helixes 
represent subunit I, green TM helixes represent subunit III, and blue subunit IV.  
 
Residue Relative activity (%) Residue 
Relative 
activity (%) 
WT 100 TI247V 173 
WI156A 70 KIII25L 75 
RI176A 70 GIII28V 88 
QI195A 121 FIII29I 115 
QI195E 137 YIII32F 60 
QI195I 64 DIII36N 131 
QI195L 119 DIII36V 160 
 
 
Table 3.2 Site-directed mutagenesis for possible QL site and its relative activities 
at Vmax.   
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 Relative activity (%) KM (𝝁𝑴) 
WT 100 50 
QI195I 64 64 
QI195A 121 39 
QI195E 137 44 
QI195L 119 67 
TI247V 173 21 
DIII36N 131 27 
DIII36V 160 15 
 
 
Table 3.3 KM assays of specific mutants from Table 3.2. 
 
5. Discussion and Conclusions 
Several membrane proteins that utilize quinone substrates have been crystallized 
and their structures determined without the bound quinone or bound with quinone 
analogues [9-11]. The initially reported structure of E. coli cyt bo3 does not have any 
ubiquinol bound to the enzyme, but the subsequent structure determined by the Stowell 
group, using a different detergent, as part of our collaboration does have two long chain 
quinones bound. Most of the protein can be accounted for in the current structure, a 
substantial improvement over the previous structure [1]. Portions of the protein are 
clearly not in the native conformation (e.g., protein helices pointing perpendicular to the 
rest of the protein) when compared to the structures of homologous cytochrome c 
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oxidases [1, 12, 13]. and the overall resolution (3.8 Å ) is still far from desired. 
Nevertheless, the data have been modeled to indicate a bound ubiquinone-8 with the 
headgroup where it is expected in the QH site and additional ubiquinone-8 bound opposite 
side of the membrane. The ubiquinone at the QH site has most of the isoprene tail units 
outside the protein, sticking out into what would be the lipid bilayer in the native 
environment. If representative of what is found in the membrane, this suggests that the 
head group and first few isoprene units (our of 8) are responsible for the binding affinity 
of ubiquinol-8. 
Site-directed mutagenesis was performed based upon the new structure to observe 
the QL binding site functionality. The data clearly do not support the identification of this 
as corresponding to the QL low affinity ubiquinol binding site. The KM was measured for 
WT cyt bo3 to be 50 µM, which is the same as previously reported [2, 3, 14]. The KM of 
the mutants showed essentially no change and, moreover, the activity of the mutants were 
also similar to the WT. Furthermore, our collaborators determined that the distance 
between the headgroups of the bound quinones at the QH and QL sites is substantially too 
large (37 Å) to be compatible with the experimental electron transfer rate from QL to QH 
[15-17]. A plausible explanation is that what has been modeled as a ubiquinone at the QL 
site is actually a phospholipid or detergent. This is suggested by the fact that in the 
structure of the homologous cytochrome c oxidase from Rhodobacter sphaeroides 
(resolution of 2.3 Å, 1M56.pdb) there is a well defined lipid site that overlaps well with 
the putative QL site of cyt bo3. (Fig 3.3) We suggest this binding site is more likely to be 
a lipid site rather than a ubiquinone binding site. 
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 Overall, the essence of this part of our study is that the new structure helps with 
filling in the missing residues and moreover shows a natural substrate bound to the 
enzyme at the QH site. However, we still have not been able to identify the low affinity 
ubiquinone binding site. The advantage of having a second ubiquinone binding site is to 
function as a transiently bound ubiquinone that is able to deliver electrons to the bound 
ubiquinone at the QH site. Therefore, the second ubiquinone binding site should be very 
close to the QH site. It is not necessary for the ubiquinone to bind tightly to the second 
site or to stabilize the semiubiquinone form in order to deliver two electrons to the bound 
ubiquinone at the QH site [2, 18].  
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Fig. 3.3 Structural comparison of top view between (left) cytochrome aa3 from 
Rhodobacter sphaeroides (IM56.pdb) and (right) cytochrome bo3 from E.coli. First 
ubiquinone (yellow) is well bound in the area known for the high affinity site (QH). In 
cytochrome aa3 the lipid is bound at the same site where in cyt bo3, ubiquinone is bound. 
The color is coded by the subunits. (black as subunit I, red as subunit II, pink as subunit 
III, and blue as subunit IV)  
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IV. TESTING BIOINFORMATICS-BASED SEQUENCE MOTIFS 
PREDICTED TO DESIGNATE THE QH AND QL UBIQUINOL 
BINDING SITES 
1. Introduction 
After enzyme purification using dodecyl maltoside (DDM) there is always a 
tightly bound ubiquinone at the high affinity site (QH) [1-6]. For the enzyme to turnover, 
either this bound ubiquinone (UQ) should rapidly exchange with ubiquinol (UQH2) in the 
ubiquinone pool (msec time scale) or a ubiquinol binds to the enzyme at a second site that 
is in rapid equilibrium with the quinone pool in the membrane and delivers the two 
electrons to the tightly bound ubiquinone. 
There has been an ongoing debate of whether there are two binding sites or only 
one [1-3, 7-12]. The high affinity binding site is well studied via sequence analysis (well 
conserved throughout the quinol oxidases) and by site-directed mutagenesis. The new 
structure shows a ubiquinone bound to this QH site. However, there is no clear evidence 
where the second binding site is located.  It has been suggested that this site is in subunit 
II [2, 8, 10]. Subunit II was most strongly implicated by using azidoquinone, a 
photoaffinity cross-linking reagent that was found to selectively bind to subunit II of cyt 
bo3 [8]. These results were viewed initially as sensible insofar as this quinol binding site 
would “replace” the site for binding cytochrome c which is in subunit II of the 
cytochrome c oxidases [8]. The subsequently determined structure of the enzyme, 
however, indicated that subunit II is far from the surface of the lipid bilayer, making it 
more challenging to determine how the quinol could bind to a site within this subunit. It 
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is noted that the recently determined structure of Complex I from Thermus thermophilus, 
which is an NADH:quinol oxidoreductase, contains a long channel allowing the quinone 
headgroup to bind to residues far above the surface of the bilayer [13]. However, the 
structure of cyt bo3 shows no such channel.  
Additional support for two ubiquinone binding sites originates from studies with 
quinone-analogue inhibitors of cyt bo3 such as HQNO and Aurachin. Kinetics studies 
showed that some inhibitors exhibit a competitive pattern and others are noncompetitive.  
The data were interpreted as having one group of inhibitors binding to the presumed QL 
site and others to the QH site [2, 3, 11]. In addition the binding of inhibitors HQNO and 
Aurachin was demonstrated to abolish the EPR signal from the bound quinone at the QH 
but did not displace the bound quinone from the enzyme [2]. All these data are consistent 
with the existence of two adjacent sites for binding ubiquinone.  
A recent paper [14] used sequence alignments, bioinformatics and molecular 
modeling to identify sequence motifs to identify both the QH and QL sites in the quinol 
oxidases. The residues identified as the QH binding motif included those already 
confirmed to be critical for enzyme activity and for stabilizing the semiquinone species 
by EPR spectroscopy, R71, H98 and Q101. Additional residues were suggested to also be 
important for quinone binding. A motif proposed to represent the QL binding site adjacent 
to the QH site was also identified. We used the residues identified in this bioinformatics 
study [14] to guide site-directed mutagenesis to test the predictions for both the QH and 
QL sites.  
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2. Methods 
Site-directed mutagenesis 
The same methods were used as in Chapter 2. All oligonucleotides were ordered 
from IDT (Integrated DNA technologies). (Table 4.1) PCR was used for site-directed 
mutagenesis using Agilent (Santa Clara, CA) kit. The sequence verification of 
mutagenesis products was performed at University of Illinois Urbana-Champaign (UIUC) 
Biotechnology Center. All chemicals of the purest grade available were used. 
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Name Primer sequences 
Q82Afor CCA TTA TGA TGC GTA GCG CGC AGG CTC TTG CCT C 
Q82Arev GAG GCA AGA GCC TGC GCG CTA CGC ATC ATA ATG G 
F93Afor CGA AGC GGG CGC ACT GCC ACC TCA C 
F93Arev GTG AGG TGG CAG TGC GCC CGC TTC G  
F93Yfor GCG AAG CGG GCT ATC TGC CAC CTC AC 
F93Yrev GTG AGG TGG CAG ATA GCC CGC TTC GC 
E164Afor CGT TTC TCT CGG CGT GGG CGC ATT TGC GCA GAC C 
E164Arev GGT CTG CGC AAA TGC GCC CAC GCC GAG AGA AAC G 
E164Kfor CGT TTC TCT CGG CGT GGG CTT TTT TGC GCA GAC C 
E164Krev GGT CTG CGC AAA TTT GCC CAC GCC GAG AGA AAC G 
F165Afor GTT TCT CTC GGC GTG GGC GAA GCT GCG CAG ACC G 
F165Arev CGG TCT GCG CAG CTT CGC CCA CGC CGA GAG AAA C 
Q167Afor GTG GGC GAA TTT GCG GCG ACC GGC TGG CTG GCC TAT C 
Q167Arev GAT AGG CCA GCC AGC CGG TCG CCG CAA ATT CGC CCA C 
Q167Kfor GTG GGC GAA TTT GCG AAG ACC GGC TGG CTG GCC TAT C 
Q167Krev GAT AGG CCA GCC AGC CGG TCT TCG CAA ATT CGC CCA C 
T168Afor GCG AAT TTG CGC AGG CCG GCT GGC TGG CCT ATC 
T168Arev GAT AGG CCA GCC AGC CGG CCT GCG CAA ATT CGC 
L171Afor GAA TTT GCG CAG ACC GGC TGG GCG GCC TAT CCA CCG 
L171Arev CGG TGG ATA GGC CGC CCA GCC GGT CTG CGC AAA TTC 
S177Afor CCT ATC CAC CGC TAG CGG GAA TAG AGT ACA GTC CGG GAG 
S177Arev CTC CCG GAC TGT ACT CTA TTC CCG CTA GCG GTG GAT AGG 
E259Afor (II) CGA AAA ACT GGC CGC GCC TAG CGC ATA CAA CCA GGT GG 
E259Arev (II) CCA CCT GGT TGT ATG CGC TAG GCG CGG CCA GTT TTT CG 
E259Kfor (II) CGA AAA ACT GGC CGC GCC TAG CAA ATA CAA CCA GGT GG 
E259Krev (II) CCA CCT GGT TGT ATT TGC TAG GCG CGG CCA GTT TTT CG 
W136Afor (II) GGT TTC CAT GGA CGC GAA ATG GTT CTT C 
W136Arev (II) GAA GAA CCA TTT CGC GTC CAT GGA AAC C 
W136Kfor (II) GGT TTC CAT GGA CAA GAA ATG GTT CTT C 
W136Krev (II) GAA GAA CCA TTT CTT GTC CAT GGA AAC C 
 
Table 4.1 List of primers used in the Site-directed mutagenesis. 
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3. Results 
The QH binding motif: First, we will see if QH has a ubiquinone binding 
motif as the Pierri group mentioned [14]. (Fig 4.1) The paper indicated that the QH 
ubiquinone binding motif is from residue R71 - Q101. In the high affinity ubiquinone 
binding motif, five residues that are aromatic, charged or hydrophilic residues were 
indicated to be potentially involved in the ubiquinone binding was chosen: R71, F93, P75, 
H98 and Q101. Previous models of the QH site have included D75 which is not included 
in the list and which mutagenesis studies demonstrate is critical for function [2, 15-19]. 
Residues F93, and P75, previously not considered, are predicted to play an important role 
in quinol interactions at the QH site. From both X-ray structures of cyt bo3 we know that 
P75 is involved in a turn [20] and not likely to directly interact with the bound ubiquinol. 
Mutations have previously demonstrated the importance of R71, D75, H98 and Q101.  
Even thought it wasn’t chosen to interact with the quinone, Q82, which is in the QH motif, 
in the sequence alignment shows to be conserved. Mutations were made to test the 
importance of both Q82 and F93 to the QH site.  
As shown in Table 4.2, replacing Q82 by an alanine has little effect on either the 
quinol oxidase activity or the KM for ubiquinol-1. Hence, there is no support for a direct 
interaction of this residue with ubiquinol at the QH site. Both the F93Y and F93A 
mutations were also studied. Each of these mutations does increase the KM for ubiquinol-
1 from 50µM (WT) to 72 µM and 91 µM respectively. In addition, the activity of the 
F93A mutant is substantially reduced to 37% of the WT activity. Hence, a role of F93 in 
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the QH site does appear to be plausible based on these data. Further studies with the F93 
mutants will be discussed in Chapter 5. 
 
 
Fig. 4.1 A) Side view of cyt bo3. The high affinity binding site (QH) motif is 
shown in orange and low affinity binding site (QL) motif in purple. The residues depicted 
as direct binding is shown in the figure. The neon green is D75, which wasn’t chosen for 
the QH binding motif, but from previous study it is well indicated as a binding site. B) 
Top view of the ubiquinone binding motifs of QH site and QL site. C) Zoomed view of the 
QH residues. (IFFT.pdb) 
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 Relative activity (%) KM 
WT 100 50 
*Q82A 88 45 
*F93Y 81 72 
*F93A 37                             91 
E164A 28 20 
E164K 54 46 
F165A 37 33 
Q167A 57 27 
Q167K 75 26 
T168A 118 31 
L171A 79 42 
S177A 91 32 
 
 Table 4.2 The ubiquinol-1 oxidase activity and KM values for mutants within 
either the QH or QL site motifs within subunit I, as designated in [14]. (*QH motif 
residues.) 
 
Fig. 4.2 Figure of Subunit I only with site-directed mutagenesis residues from 
Table 4.2. The red residues indicate the QH residues (R71, D75, H98, and Q101). 
(IFFT.pdb) 
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The QL binding motif: Site-directed mutagenesis was performed to alter 
most of the residues in the QL ubiquinone binding motif within subunit I (G163 – Y173) 
except for glycine and alanine residues. E164 and Q167 were predicted [14] to have a 
direct interaction with the ubiquinone/ubiquinol moiety. S177 was not depicted as a QL 
site residue, but due to the location nearby the QL motif, the S177A mutant was also 
made. (Fig 4.2) Results are summarized in Table 4.2. None of the mutations resulted in a 
substantial increase in the KM of ubiquinol-1. Neither E164 nor Q167 are essential for 
function though mutations in each lead to lower oxidase activity. E164A has a perturbed 
heme absorption spectrum (not shown) and only 28% of the activity of the WT enzyme.  
However, the more drastic mutation E164K does not result in any spectroscopic 
perturbation and retains 54% of the activity. In summary, these mutations provide no 
support for residues in the putative QL motif being important for substrate binding. 
 
 
 
 
 
Fig 4.3 (Left) Side view of cyt bo3 with site-directed mutagenesis residues shown. 
The subunit I residues are the QH site, and the subunit II residues are the possible QL site. 
(Right) top view of the two possible residues for QL site. The QL site residues are right on 
top of the QH site. (IFFT.pdb) 
	   63 
Several mutations were also made in subunit II to examine possible effects on the 
interaction of ubiquinol with the enzyme. As shown in Fig 4.3, WII136 and EII259 are just 
above of the QH site. At one point, WII136 was suggested to be part of the QL site [10] 
though subsequent examination indicated this was not likely [2]. We tested the 
hypothesis that the region adjacent to and just above the QH site might provide room for a 
second ubiquinol to bind (i.e., the QL site). We characterized the following mutants: 
WII136A, WII136K, EII259A and EII259K. The results, summarized in Table 4.3, show 
that these mutations have virtually no effect on either the oxidase activity or the KM of 
ubiquinol-1.    
 Relative activity (%) KM 
WT 100 50 
WII136A  89 33 
WII136K 105 39 
EII259A  135 27 
EII259K  97 27 
  
Table 4.3 Site-directed mutagenesis of subunit II residues for possible QL site. 
 
There was no change in the KM after mutating either to alanine or lysine. This was 
shown before, and we have verified again that it isn’t the case [2].  
 
 
 
	   64 
4. Discussion and conclusions 
Many membrane enzymes use quinone as a substrate. To identify the quinone 
binding site a number of approaches have been used including X-ray crystallography with 
small quinone analogues soaked into the crystals [21], using photoreactive quinone 
analogues and determining the binding site(s) by protein analysis [10, 22-25], and by site-
directed mutagenesis combined with steady state kinetics with both substrates and 
inhibitors to determine changes in Ki or KM values [2, 3, 6, 11, 12, 23-31]. Key residues 
in the QH site of cyt bo3 have been defined by crystallography and mutagenesis [1, 2, 7, 
18, 19], and a second site has been inferred to exist based the use of a photoreactive 
quinone analogue and steady state kinetic patterns. The initial suggestion for the 
existence of two ubiquinone binding sites derives from the fact that preparations of the 
enzyme could be obtained with 2 equivalents of ubiquinone, though no evidence showed 
that both were actually bound to the enzyme as opposed to co-purifying along with other 
lipids [3]. 
In this chapter we have used site-directed mutagenesis to locate the QL site, 
guided by a recent bioinformatics analysis [14] that identified motifs in the quinol 
oxidases predicted to designate both the QH and QL sites. Extensive analysis of mutations 
altering virtually all of the residues suggested to comprise the QL site gave no evidence in 
support of this claim. In addition, mutations which would be expected to disrupt a second 
quinol binding site above the QH site at the interface with subunit II, revealed no evidence 
for a separate QL site at this location in the protein. In Fig. 4.4 every residues that was 
used to search for QL site is shown. Our studies leave us with the question; where is the 
QL site and does it even exist?   
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Further tests were made to examine the importance of residues predicted to 
comprise the QH site. Besides the residues already known to interact with the 
semiquinone stabilized at the QH site, only one additional residue, F93 was implicated in 
quinone binding at the QH site. Additional important information on the properties of the 
F93Y and F93A mutants is shown in the next Chapter.  
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 Fig 4.4 The figure shows all the residues that have been mutated in this 
study. Grey as subunit I, blue as subunit II, orange as subunit III, and red as subunit IV. 
The QH site residues are written in red colors. (IFFT.pdb) 
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V. REINVESTIGATION OF QH UBIQUINONE BINDING SITE  
1. QH ubiquinone binding site 
1. Introduction 
The number of ubiquinone binding sites in cyt bo3 has been an ongoing question. The 
high affinity site QH site was identified from sequence homology and from the X-ray structure 
[1] and confirmed by site-directed mutagenesis [1-4]. The residues are well conserved and using 
site-directed mutagenesis, steady state enzymatic activities were measured, and moreover 
different biophysical methods such as EPR, FTIR, redox potential, and other methods were used 
to identify the core residues at this site [1, 3-12]. Although a careful and detailed study was 
performed to identify the second ubiquinone binding site, the data summarized in the previous 
Chapter suggests that perhaps there may be no separate QL site. As mentioned by Iwata and 
Wikström group, there may be only one ubiquinone binding site, which will be sufficient as long 
as the quinone bound at this site could rapidly exchange with the pool of free quinone in the 
membrane [1, 11, 13]. If the QH site is the only quinone binding site then it would be expected 
that some mutations at this site would alter the KM for ubiquinol-1 and also perturb the binding of 
quinone-analogue inhibitors such as HQNO, thought to interact at the QL site [14-17]. As shown, 
these properties are observed, leading to the conclusion that there is only one quinone binding 
site, defined as the QH site. 
The QH site core is composed of four residues: R71, D75, H98, and Q101. (Fig 5.1) Any 
site directed mutagenesis in R71 and H98 makes the enzyme inactive and makes kinetic assays 
impossible. Among the most studied residues in the QH site is D75 [2-5, 9, 10, 18]. The one 
exception is D75E, which retains activity and has been studied [2]. So far, the last QH site 
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residue, Q101, has not been extensively studied. Q101N was shown by the Wikström group [1] 
to retain about 24% activity with an increase in the KM (four-folds) for ubiquinol-1. The same 
mutant was examined by Yap et al. [2] who observed only 5% residual activity and the absence 
of a ubisemiquinone EPR [1, 2]. In addition to these core residues, we observed that mutations of 
F93 also alter the ubiquinol-1 oxidase activity as well as the KM. F93 was selected from the 
proposed QH sequence motif by the Pierri group [19]. The location of F93 in relation to the other 
residues in the QH site is shown in Figure 5.1. In this chapter, we will study a new set of Q101 
mutants along with further studies on the mutations of F93.  
 
Fig. 5.1 QH site residues with F93. Subunit I as black, subunit II as red, subunit III as 
cyan, and subunit IV as blue. (IFFT.pdb) 
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2. Methods  
Site-directed mutagenesis  
The same methods were used as Chapter 2. All oligonucleotides were ordered from IDT 
(Integrated DNA technologies). (Table 5.1) PCR was used for site-directed mutagenesis using 
Agilent (Santa Clara, CA) kit. The sequence verification of mutagenesis products was performed 
at University of Illinois Urbana-Champaign (UIUC) Biotechnology Center. All chemicals, the 
purest grade available were used. 
 
Name Primer sequences 
Q101Afor CCT CAC CAC TAC GAT GCG ATC TTT ACC G 
Q101Arev  CGG TAA AGA TCG CAT CGT AGT GGT GAG G 
Q101Nfor CCT CAC CAC TAC GAT AAT ATC TTT ACC GCG CAC  
Q101Nrev GTG CGC GGT AAA GAT ATT ATC GTA GTG GTG AGG 
Q101Tfor CCT CAC CAC TAC GAT ACG ATC TTT ACC G 
Q101Trev CGG TAA AGA TCG TAT CGT AGT GGT GAG G 
Q101Lfor CCT CAC CAC TAC GAT CTG ATC TTT ACC GCG CAC 
Q101Lrev GTG CGC GGT AAA GAT CAG ATC GTA GTG GTG AGG 
Q101Mfor CCT CAC CAC TAC GAT ATG ATC TTT ACC GCG CAC G  
Q101Mrev CGT GCG CGG TAA AGA TCA TAT CGT AGT GGT GAG G 
 
Table 5.1 List of primers used in the Site-directed mutagenesis. 
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     Steady state enzymatic activity assay 
The steady state oxygen reduction activity of cyt bo3 was measured at 25  °C using 
Unisense Oxygen MicroRespiration sensor (Aarhus, Denmark) that has an oxygen electrode 
chamber of 1 𝑚𝑙. The temperature was cooled by water that flows around the chamber. The 
reaction mixture was made using 50 𝑚𝑀 Kpi, pH 7.0, 0.05% DDM with 2 mM dithiotherol and 
~300 𝜇𝑀 ubiquinone-1 (Q1, Sigma, Saint Louis, MO) with constant stirring. For the ubiquinone-
2 (UQ2, Sigma) measurement, concentration of 250 𝜇𝑀 was used with the same condition as 
others. The oxygen saturated buffer at 25 °C is estimated to be around 250 𝜇𝑀 [20]. With all 
substrates added, the reaction was initiated as soon as 𝑝𝑀 amount of enzyme was added into the 
mix. Turnover number (e-1/sec/enzyme) of the enzyme was calculated based on the consumption 
of oxygen slope and subtracting the background slope prior to the addition of the enzyme. The 2-
n-Heptyl-4-hydroxyquinoline N-oxide (HQNO) inhibitor (Enzo Life Sciences, Farmingdale, NY) 
was used for measurement of inhibition with saturated amount of substrate Q1 (300  𝜇𝑀) with 
DTT.  
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Fig 5.2 Quinone analogues structures A) ubiquinone-1 B) 2-n-Heptyl-4-
hydroxyquinoline N-oxide (HQNO) C) ubiquinone-2 D) ubiquinone-n structure E) Aurachin 
(AC-10) 
 
     Preparation of EPR samples 
The preparation of the sample was made the same as previously reported [2]. The 
concentrated enzyme was dialyzed against 50 mM KPi buffer, pH 8.3, 0.05% DDM, 10% 
glycerol and 10 mM EDTA. The enzymes were concentrated up to ~300 𝜇𝑀 and 110 uL was 
used. The enzyme was anaerobically reduced under an argon atmosphere with 500 × excess 
sodium ascorbate, incubated for four hours and then the reduced sample were transferred into 
argon-flushed EPR tube, with rapid freezing in liquid nitrogen.  
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3. Results  
Steady state kinetics: kcat and KM of ubiquinol-1: The QH site was well studied 
by the previous group member Lai Lai Yap [2]. Several mutations were repeated for comparison 
with new mutants at the QH site. The current work goes beyond previous studies by measuring 
the KM of ubiquinol-1 for each mutant in the QH site, shown in Table 5.2. The relative activities 
of the QH site mutants in the current work are similar to what has been reported [2]. From the 
collection of mutants in R71, D75 and H98, only D75E had activity (48%), but the KM for 
ubiquinol-1 was not increased. 
 
Residue Relative activity (%) KM (𝝁𝑴) 
WT 100 50 
D75E 48 16 
D75H 1 - 
R71Q 3 - 
H98N 3 - 
H98T 4 - 
 
Table 5.2 QH site mutations with relative activity at Vmax and KM measurement. 
 
Q101 was mutated to various amino acids. (Table 5.3) Most of the Q101 mutants have 
high activity compared to the other QH site mutants confirming that Q101 is not essential for 
oxidase function. However, the Thr, Asn, and Leu mutants show increased KM for ubiquinol-1, 
which is consistent with what we expect for a QL site mutant. Neither Q101A nor Q101M show 
an increase in the KM. For Q101A the mutant may behave like the WT oxidase due to the small 
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size of Ala, allowing the water that might able to bind between the ubiquinone and the residue, 
without changing the interaction with the ubiquinone and the enzyme. For Q101M, the side chain 
is the same length as that of glutamine and perhaps the sulfur can form a H-bond to the 
ubiquinone. The mutations of F93 also had lower ubiquinol-1 oxidase activity and, similar to the 
results with the Q101 mutants, the KM was also significantly increased, as reported in Chapter 4. 
 
Residue Relative activity (%) KM (𝝁𝑴) 
WT 100 50 
Q101A 26 30 
Q101N 10 72 
Q101T 27 200 
Q101L 11 141 
Q101M 51 24 
F93Y 81 72 
F93A 37 91 
 
Table 5.3 Q101 residue with different site-directed mutagenesis and its relative activity 
at Vmax and KM measurement. 
 
Inhibition by the QL-site inhibitor HQNO: Each active mutant was also studied 
for the inhibition by HQNO. (Table 5.4) As shown, the apparent Ki of UQ1H2 of WT is 0.68 𝜇𝑀. 
The Ki of HQNO for Q101A is also in the same range, 0.86 𝜇𝑀. Each of the other active QH-site 
mutants, Q101M, Q101N, Q101L, Q101T and D75E, show a substantial increase in the Ki of 
HQNO, as much as 8-fold increase. This is also observed for both of the mutants which do not 
show an increased KM for ubiquinol-1, Q101M and D75E. Furthermore, the extent of inhibition 
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by HQNO at saturation levels is significantly reduced, particularly in the Q101L and Q101N 
mutants. Similar results were also shown for both the F93Y and F93A mutants, though the 
magnitude of the increase in the Ki was not as great as with the other mutations shown in Table 
5.4. These new data with HQNO provide independent evidence that the residues which are 
known to stabilize the semiquinone at the QH site also are important for interactions expected at 
the putative QL site. In sum, the data are consistent with only one site for quinone binding.  
 
Residue Kappi (𝝁𝑴) Max % of inhibition 
WT 0.68 99 
Q101A 0.86 86 
Q101N 5.44 63 
Q101T 4.77 88 
Q101L 3.97 67 
Q101M 3.35 89 
D75E 5.75 90 
F93Y 2.69 108 
F93A 2.21 99 
 
Table 5.4 Q101 mutants with inhibitor HQNO and its Kappi measurement with relative 
inhibition.  
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Fig 5.3 EPR spectra of the semiquinone formed by UQ8 bound at the enzyme.  
 
Bound ubiquinone-8 and the stabilization of the ubisemiquinone: 
Previously it was shown that mutants in R71, D75 and H98 which inactivate the enzyme do not 
result in the loss of the bound ubiquinone-8 [1, 2]. However, most of these mutants (exceptions 
being D75E and D75H) [2] do not stabilize the semiquinone at the QH site. The same 
measurements were made for the mutations in Q101 and it is shown that in all cases the content 
of bound ubiquinone-8 remains the same as in the WT enzyme (Table 5.5), and that most of 
these mutants also stabilize the semiquinone, albeit with a perturbed EPR signal. As reported 
previously [2], Q101N, which in our hands has very low activity, fails to stabilize the 
semiquinone. As shown in Fig 5.3, for all of the other Q101 mutants the semiquinone was 
formed. Q101A shows a spectrum identical to that of the WT enzyme. Q101M shows a large 
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increase in the intensity of the EPR signal, whereas the signal is attenuated for Q101L and 
Q101T. In addition, the EPR spectrum of Q101L and Q101T has an altered shape due to much 
smaller methyl hyperfine coupling [21] which is observed as the shoulder in the high field 
portion of the spectrum of the WT, Q101A and Q101M mutant. Both the F93Y and F93A 
mutants also stabilized the semquinone at the QH site and the spectra each have the shoulder 
indicating the methyl hyperfine coupling as in the WT enzyme. The EPR spectra of the F93 
mutants are shown in Figure 5.4 along with that of the WT enzyme. It is apparent that the 
magnitude of the EPR signal is increased, particularly for the F93Y which is similar to Q101M.  
The results are organized in Table 5.6. 
 
Cyt bo3 
Relative activity 
(%) Quinone content 
WT 100 1.1 
D75E 48 1.7 
D75H* 4 0.9 
D75N* ~0 1.3 
R71D* ~0 1.4 
R71K* ~0 1.3 
R71Q 3 1.1 
H98S* 2 1.4 
 
Table 5.5 QH mutants relative activity at Vmax and its quinone content measured by 
HPLC. (* Reported as [2].) 
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Fig 5.4 The EPR spectra of WT, F93A and F93Y. F93Y has more than 3 fold of increase 
in intensity corresponding to strong semiquinone formation. 
 
Residue EPR signal Methyl hyperfine coupling 
WT Yes Yes 
Q101A Yes Yes 
Q101N No No 
Q101T Yes No 
Q101L Yes No 
Q101M Yes Yes 
F93Y Yes Yes 
F93A Yes Yes 
 
Table 5.6 The EPR signal of semiquinone formation and methyl hyperfine coupling. 
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Steady state kinetics with ubiquinol-2: The steady state kinetics measurements 
reported so far, were made with soluble ubiquinone analogue, UQ1. However, it is well known 
that soluble ubiquinone analogue, UQ2, with a longer isoprenoid chain can also be used as a 
substrate [22-25]. Table 5.7 shows the relative activity using UQ2 at 250 𝜇𝑀. Generally, the 
quinol oxidase activity with UQ2 is less affected by the QH-site mutants compared to the WT 
than the comparable measurements using UQ1. This is likely due to the longer isoprenoid chain 
of UQ2 increasing the binding affinity to the enzyme [12, 22, 23]. The Q101 mutants that had 
low activity with UQ1, e.g., Q101L, Q101T and Q101N, retained up to 60 % activity using UQ2, 
while the Q101A has 80 % and Q101M has 70 % of the WT activity. D75E, F93A and F93Y 
have virtually no loss of activity when using UQ2 as the substrate. Unfortunately, activity with 
UQ2 was often biphasic (Fig 5.5), and previous results from other groups indicate substrate 
inhibition at high concentrations [22, 23]. Therefore, obtaining consistent and reliable KM values 
was not possible.   
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Relative activity (%) 
UQ2 
Relative activity (%) 
UQ1 
biphasic 
WT 100 100 Yes 
R71Q 8 3 - 
H98N 10 3 - 
H98T 9 4 - 
D75E 88 45 Yes 
Q101A 82 26 Yes 
Q101N 61 10 No 
Q101T 62 27 No 
Q101L 58 11 No 
Q101M 72 51 Yes 
F93Y 107 81 Yes 
F93A 102 37 Yes 
 
 
Table 5.7 The relative activity using UQ2 at 250 𝜇𝑀. For specific mutants, a biphasic 
curve was seen.  
 
Fig. 5.5 Oxygen utilization due to UQ2 oxidase activity. As seen, two phases can be 
identified. All the measurements for relative activity were done using the slow phase. The two 
phases do not appear in the same timeframe. 
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2. Residue F93 – is this a ubiquinone binding site?  
1.    Results  
As mentioned from previous chapter, F93 was mentioned to be one of the QH motif site. 
Since we have studied a new method to identify the QH site residues, the steady state kinetics 
will be measured upon this residue. As shown in Fig. 5.1, F93 is located on the loop close to the 
QH site. Residue F93 is about 70 % conserved including Tyr. This residue has never been studied 
before. Table 5.8 shows results for the steady state enzyme kinetics of the KM and apparent Ki for 
F93, as studied before with Q101. The F93 mutants are as active as WT. The KM for both 
mutants has 1.5 to 2 fold increase. The apparent Ki was measured using HQNO and UQ1. This 
measurement shows an elevation of Ki of 3~4 folds. The Ki is not as high as the other Q101 
residues. The % of inhibition is complete.  
 
 
 
 
Table 5.8 Mutation of residue F93 and its relative activities with KM and Kappi.   
 
Next, EPR was measured. (Table 5.9) EPR shows that the semiquinone is formed and has 
methyl hyperfine coupling. As Fig 5.4, both the mutants have higher semiquinone yield 
 
Relative 
activity (%) KM K
app
i 
Max % of 
inhibition 
WT 100 50 0.68 99 
F93Y 81 72 2.69 108 
F93A 37 91 2.21 99 
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compared to the WT. When measuring the steady state kinetics using soluble UQ2, the mutants 
have high activity without any decrease. As shown in the other Q101 mutants, D75E, and WT, 
the F93 mutants also show biphasic character. 
 
 
Table 5.9 The EPR measurements were performed on the mutants. Both we can see the 
semiquinone formation and methyl hyperfine coupling from the mutants. The different soluble 
quinone analogue UQ2 was used for steady state kinetics.  
 
3. Discussion and conclusions 
In this Chapter it is demonstrated that some mutations in QH-site residues show 
phenotypes expected of QL-site mutants: an increase in the KM of ubiquinol-1 and an increase in 
the Ki of the inhibitor HQNO. In addition, many of the new mutations reported here show a 
perturbed EPR signal from the semiquinone, which defines the quinone bound at the QH site.   
The increase in the KM of Q101N was initially reported from Wikström group in 2000 [1]. In 
their preparation, they had used two types of enzymes: ubiquinone depleted version (Triton X-
100 purified enzyme) and ubiquinone bound version (DDM purified enzyme). As mentioned in 
chapter 2, their preparation had many problems including mixed heme ratio between oo3 and bo3. 
 EPR Signal Methyl hyperfine coupling 
Relative activity (%)  
UQ2 
biphasic 
WT Yes Yes 100 Yes 
F93Y Yes Yes 107 Yes 
F93A Yes Yes 102 Yes 
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Therefore, the measurement was not accurate. These problems of heme content and the resulting 
heterogeneity of the enzyme preparations have been resolved and the WT and all mutants 
showed the expected ratio of heme b :heme o of 1:1.  Data presented in the previous chapter 
included an exhaustive search for residues defining an independent QL-site, and the results 
yielded nothing. For this reason, in this chapter we pursue the possibility that the QH-site is the 
only quinone binding site in cyt bo3. We obtained a set of mutants among the core residues of the 
QH-site which retained significant oxidase function and used steady state kinetics with ubiquinol-
1 to determine the KM for this substrate as well as the Ki of the QL-site inhibitor HQNO. 
Increases in these two parameters provide independent phenotypes expected for mutants that 
perturb the substrate binding site. 
Whereas most previous studies of QH-site mutants focused on inactive R71 and H98 
residues, our new focus was to obtain mutants that largely retained activity. In addition to D75E, 
previously shown to be highly active [2], we determined that Q101 as well as F93 could be 
mutated without eliminating function. Previous pulsed EPR measurements showed that Q101 
interacts with the semiquinone that is stabilized at the QH-site [2]. The current work, however, 
shows that mutations at this site have effects expected for perturbing the QL-site. The results 
include substantial increases in the KM for ubiquinol-1 and, even more dramatically, an increase 
in the Ki of HQNO by up to 9-fold over the value of the WT enzyme. Furthermore, the Q101L 
and Q101N were inhibited by only about 60 % even at saturating concentrations of HQNO.  
Whereas the Q101 and F93 mutants exhibit “QL-site” phenotypes, they also show 
perturbed EPR signals from the ubisemiquinone that is located at the QH-site, leading to the 
obvious conclusion that there may only be one quinone binding site and that involves the 
residues identified as the QH-site. This still leaves us with a puzzle of how to explain the data 
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previously used to justify the two-site model. The strongest data are those that demonstrated that 
1) One equivalent of HQNO can bind to the purified enzyme without displacing the “tightly 
bound UQ8; and 2) Catalytic turnover of UQ1 did not displace the ubiquinone-8 bound to the 
purified enzyme. These appear to necessitate at least one additional binding site in addition to 
that where UQ8 is bound at the QH-site. We are now forced to re-evaluate the previous 
interpretation of these data.   
There appear to be two plausible explanations.  
Model 1: Two quinone binding sites that share interactions with some 
critical residues. One explanation is that there are two quinone binding sites but that they 
share critical interactions with the same set of residues, including at least Q101 and D75. One 
site binds the “tightly bound” quinone and stabilizes the semiquinone. The second site overlaps 
the first but can bind a second quinone as well as inhibitors such as HQNO without displacing 
the quinone from the first site.   
Model 2: One quinone binding site. A one-site model would require that the 
“tightly bound” quinone that is isolated with the enzyme is primarily bound through hydrophobic 
interactions with the isoprenoid “tail” of the quinone. This would allow the small soluble UQ1 
and HQNO to displace the headgroup of the bound ubiquinone-8 but would not displace the 
bound quinone. This model is supported by the fact that none of the mutations in R71, D75, 
Q101 or H98 result in dislodging the bound quinone although the ability to form the 
semiquinone is usually eliminated. Previous data showed virtually no change in the binding of 
HQNO to the purified cyt bo3 due to the presence of the bound ubiquinone-8, which would 
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require that very little if any of the binding free energy results from interactions with the 
headgroup.   
It might be expected that displacing the UQ8 from the isolated enzyme in a detergent 
micelle would be difficult due to the size and hydrophobicity of the long isoprene tail of UQ8.  
However, the mutations in the QH-site residues must be bound to UQ8 within the E. coli 
membrane, which is a very different environment from the small detergent micelle. Hence, it is 
reasonable to conclude that the binding of the UQ8 to cyt bo3 is primarily through hydrophobic 
interactions with at least part of the isoprene tail and not due to strong interactions with the 
quinone headgroup. 
The fact that the mutations in Q101 and as well as F93A and D75E exhibit much less 
effect on the activity using UQ2 in place of UQ1 is also consistent with this conclusion. Since 
UQ2 has a longer and more hydrophobic tail, it would be expected to bind more strongly to the 
quinone binding site and, perhaps, be better able to overcome the effect of these mutations which 
do not apparently block essential steps in the catalytic mechanism further downstream from the 
initial binding. However, the presumed stronger binding through the isoprene tail would also 
necessitate that UQ2 cannot bind without displacing the bound UQ8 that is bound in the same site 
if there is only one-site. This is examined in the next chapter 
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VI. EXCHANGE OF THE BOUND UBIQUINONE-8 WITH 
EXOGENOUSLY ADDED QUINONES  
1.    Introduction 
After purification using the detergent DDM there is a “tightly bound” ubiquinone at the 
QH site of cyt bo3. This “tightly bound” quinone was thought to be a cofactor by experiments that 
showed that even in the presence of excess substrate UQ1H2 the bound UQ8 remains bound to the 
enzyme [1]. In an experiment in which buffer containing excess UQ1H2 was flowed through the 
Ni-NTA resin to which cyt bo3 was bound, there was no displacement of the bound quinone with 
the soluble quinone. [1] In addition, the binding of the inhibitor HQNO occurs in the presence of 
bound UQ8 with the same binding constant and stoichiometry [1]. These experiments supported 
the view that the bound quinone does not exchange with exogenous ubiquinones or quinone 
analogues. On the other hand, once the UQ8 is removed from the enzyme, such as by treatment 
with Triton X-100 or by isolating the enzyme from a strain of E. coli that does not synthesize 
ubiquinone [2, 3], small quinones such as UQ1 or analogues bind readily and can even form 
stable semiquinones at the QH-site [2, 4-6]. However, quinones with long isoprenoid chains such 
as UQ8 or UQ10 require overnight treatments, at best, to occupy the vacant QH site [2, 3].   
Quinones with short isoprenoid chains (or none) such as UQ1 are much more water-
soluble than the natural substrates, UQ8 or UQ10. The natural substrates present significant 
experimental problems with membrane enzymes that are characterized in detergents such as 
DDM. To a large extent it is not possible to simply add UQ8 in a detergent micelle to the 
enzyme, also in a detergent micelle. This is why UQ1 is routinely used (along with decyl-
ubiquinone, which has an alkyl chain in place of the isoprene side chain) as the preferred 
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substrate for in vitro studies. The long and short chain quinones are very different in this regard. 
Even within the lipid bilayer, the long and short chain quinones behave differently as they 
partition between the middle and surface of the bilayer [7, 8]. Depending on the length of the 
quinones, shorter chain quinones preferably locate near the surface, while the longer chain 
quinones spend longer times at the midplane [8]. It has been shown that the tails are associated 
with the binding of the enzymes; therefore using short tails might not be an accurate 
measurement for quinone binding measurements [9-13]. 
One approach which has been used to avoid these difficulties is to examine the membrane 
enzymes in reconstituted lipid bilayer or within the natural membrane. One example is CymA, a 
tetraheme quinol dehydrogenase which is a monotopic membrane enzyme that normally sits on 
the surface of the membrane bilayer and oxidizes the quinol within the membrane. This enzyme 
has been studied using reconstituted liposomes containing menaquinone [14]. Using vesicle-
bound apo-enzyme it was shown that the water-soluble menaquinol (MK0) does not bind to the 
enzyme while the long isoprenoid tail of MK7 facilitates the guidance of the substrate to the 
binding site. This study illustrates that the way in which a membrane enzyme interacts with 
water-soluble analogues of the natural hydrophobic quinone substrate can be very different and 
exhibit very different kinetics. 
Four experiments are described in this chapter in which the exchangeability of the long 
chain UQ8 at the QH site is re-examined. Each experiment demonstrated that the UQ8 bound to 
the QH site of cyt bo3 is not irreversibly bound to the enzyme, but could be displaced or replaced 
at least within minutes. The data make it plausible that the QH site is the only quinone binding 
site in cyt bo3.  
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o Experiment 1: UQ10 was inserted into E. coli membranes containing cyt bo3 along with 
its natural substrate UQ8. The enzyme was solubilized in DDM and isolated and the 
quinone content was determined to see if the exogenously added Q10 would displace the 
natural UQ8 in the QH site. 
o Experiment 2: Purified cyt bo3 containing one equivalent of UQ8 was reconstituted with 
phospholipids to form proteoliposomes without any additional quinone species. The 
enzyme was solublilized and re-isolated and the quinone content was measured. The 
purpose of this experiment is to see if the bound UQ8 would partition into the lipid 
bilayer and deplete the occupancy of the QH site due to this dilution.   
o Experiment 3: The purified cyt bo3 was reconstituted into proteoliposomes which 
contained UQ10. After re-isolation of the enzyme, it was determined if UQ10 had replaced 
UQ8 at the QH site. In addition, the monotopic membrane enzyme NDH-2 from E. coli 
[15, 16] was used to reduce the pool of UQ10 in the reconstituted liposomes to measure 
the ability of the reduced UQ10 to be re-oxidized by cyt bo3. This was determined by 
measuring the depletion of O2 in the solution. 
2𝑁𝐴𝐷𝐻  +   2𝐻  +   𝑄   ↔   2𝑁𝐴𝐷!   +   𝑄𝐻! 
o Experiment 4:  Purified, recombinant cyt bo3 was bound to the Ni-NTA column in the 
presence of the detergent DDM. Several column volumes of buffer containing either UQ2 
or UQ4 were rapidly flowed over the bound enzyme, which was immediately eluted from 
the column. This repeats the same experiment previously performed using UQ1, which 
did not displace the UQ8. The quinone content of the enzyme was determined to 
determine if quinone species with longer isoprenoid side chains, but more soluble than 
UQ8 or UQ10, could displace UQ8 even in detergent micelles. 
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2. Methods 
Fusing UQ10-containing liposomes with E. coli membranes  
 Unilamellar UQ10 containing liposomes were prepared with 2 𝑔 of asolectin (mixed 
soybean phospholipid) and 13.5 𝑚𝑔 of UQ10 dissolved in 6 𝑚𝑙 of chloroform [5, 17]. The mix 
was evaporated to dryness under nitrogen gas. (Around 2 hours.) After drying the mixture, 11 𝑚𝑙 
of 50 mM Tris-Cl (pH 8.0), 0.1 mM EDTA, 200 mM NaCl, 10 % glycerol buffer was added and 
resuspended till the mixture was well hydrated. (Hydration took around 3 hours.) Sonication was 
performed 10 times with a 30 s period at 4 °C. The liposomes were mixed with 10 𝑚𝑙 amount of 
an E. coli membrane suspension (collected from ~ 3L cell culture). Buffer was added to the 
mixture, bringing it up to 30 𝑚𝑙. This was then incubated for one hour in the shaker. Fusion was 
accomplished by using the flash-freeze method with liquid nitrogen. After freezing, the 
membrane-liposome mixture was thawed and then sonicated twice for 30s at 4 °C. Again using 
liquid nitrogen this process was repeated four more times. The volume was increased up to 45 𝑚𝑙 by adding buffer. Ultracentrifugation at 42 K rpm for 2 hours was performed. The pellets 
were collected and resuspended to a final volume of 50 𝑚𝑙 of 50 mM KPi buffer. The 
membranes were solubilized with 1 % of DDM for 2 hours followed by ultracentrifugation at 40 
K rpm for 1 hour at 4 °C to remove insoluble material. The purification of cyt bo3 is the same as 
previously described. 
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Quinone extraction from purified cyt bo3 and analysis by HPLC 
A known amount of purified enzyme (about 5 nmoles in 500 µl) was aliquoted into glass 
tubes along with the equimolar amount of standard either MK7 extracted from Bacillus subtillis 
or purchased UQ10. After mixing, 3 ml of methanol:petroleum ether (3 : 2.3) solvent was added 
to the mixture followed by vigorous vortex and centrifugation. The upper organic layer 
containing the ubiquinones was extracted and transferred into an empty vial and was dried under 
nitrogen gas. The remaining mixture was extracted with 3 𝑚𝑙  of the same solvent two more 
times. This organic solvent containing the extracted ubiquinone was dried and the residue 
dissolved in pre-filtered solvent used as the mobile phase for HPLC, acetronitrile: methanol: 
ethanol = 3:3:4. The quinone species were resolved using a microsorb-MV 100-5 C18 reverse-
phase HPLC column (Varian, Palo Alto, CA). 
 
Formation of reconstituted proteoliposomes using DOPC  
10 𝑚𝑔 of DOPC lipids with or without UQ10 was transferred into a round-bottomed flask 
and then small amount of chloroform was added until the lipids were dissolved. The liquid was 
dried under nitrogen flow and then placed under vacuum for at least 4 hours to completely 
remove the chloroform. The dried lipids were resuspended in 10 𝑚𝑙 of 20 𝑚𝑀 Hepes-NaOH, pH 
7.4. The lipid suspension was subjected to five cycles of freeze-thaw using liquid nitrogen and 
then treated with an extruder kit from Avanti (Alabaster, AL) to make unilamillar vesicles of 
predetermined sizes. Large vesicles (>800 𝑛𝑚) were initially used and then the size was 
decreased to 200 𝑛𝑚. Extrusion was performed multiple times (over 17) to assure a uniform size 
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distribution of the vesicles. The multilamellar vesicles were frozen -20 °C for further use or, if 
not used in several weeks, it was stored at -80 °C. 
 The suspension of multilamellar vesicles (470 µl containing about 470 µg of 
phospholipid) was combined with 17 µl Na-cholate (20% stock) 1 𝑢𝑀 of a solution containing 
enzyme. The enzyme should be as concentrated as possible so the amount of DDM in the final 
mixture was minimal. The mixture is incubated at room temperature for 30 min with occasional 
mixing by tapping the tube. The ~ 500 𝑢𝑙 sample was loaded onto a PD10 column and eluted 
with buffer without any detergent. The enzyme was collected in about 1.5 𝑚𝑙 and used without 
storage. 
 
Quinone extraction from cyt bo3 in reconstituted liposomes 
Although cyt bo3 could be readily solubilized from E. coli membranes using 2% DDM, 
this was found not to be the case for cyt bo3 that was reconstituted into proteoliposomes using 
either asolectin or DOPC regardless of whether UQ10 was also present. This observation is 
consistent with studies from the Møller group, which examined the effectiveness of different 
detergents to solubilize phospholipid vesicles [18]. For this purpose DDM is very ineffective, but 
Triton X-100 is the most efficient detergent.  However, we could not use Triton X-100 because 
this would also strip the quinone bound to the QH site [19]. The protocol that was successful to 
solubilize cyt bo3 from reconstituted proteoliposomes required a 2 hr incubation in the presence 
of 10% DDM. The liposome suspension became translucent by this treatment and the cyt bo3 
was isolated using the Ni-NTA column, washing the column with 0.05% DDM, 50 mM KPi 
buffer at pH 8.3, followed by elution using 150 mM imidazole in the same buffer. 
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Steady state enzymatic activity assay using liposomes 
The steady state oxygen reduction activity of cyt bo3 liposomes was measured at 25  °C 
using a YSI model 53 oxygen electrode (Yellow Springs Instrument Co., Yellow Springs, OH) 
that has an oxygen electrode chamber volume of 1.8 mL. The temperature is maintained by using 
a circulating water bath. The reaction mixture was made using 50 mM Kpi, pH 7.0, 0.05% DDM 
with 9 pmol enzyme. The oxygen saturated buffer at 25 °C is estimated to have an oxygen 
concentration around 250 𝜇𝑀. With all substrates added, the reaction is initiated by the addition 
of 2 𝑢𝑙 of 6 𝑢𝑔/𝑚𝑙 of NDH-2 (0.143  𝑛𝑚𝑜𝑙). The turnover number (𝑒!!/sec/enzyme) of the 
enzyme is calculated based on the rate of oxygen consumption after subtracting the background 
slope prior to the addition of the enzyme.  
 
Exchange of UQ8 by UQ2 using purified enzyme in DDM  
 Two methods were used.  
1. Exposing the enzyme to UQ2 prior to re-isolation of cyt bo3 with the Ni-NTA 
column: 2.5 𝑢𝑀 (5 𝑛𝑚𝑜𝑙) cyt bo3 was added to 1.8 𝑚𝑙 of 1% DDM, 50 mM KPi buffer 
at pH 7. To this was added various amounts of UQ2 (Sigma) and the mixture was 
incubated for the stated times. Adding the reductant DTT to reduce UQ2 and initiate 
enzyme activity made no difference to the final result. After incubation, the mixture was 
loaded onto the Ni-NTA column and washed thoroughly using 0.05% DDM, 50 mM KPi 
buffer at pH 8.3. The enzyme was eluted using 150 mM imidazole, 0.05% DDM, 50 mM 
KPi buffer at pH 8.3.  
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2. Exposing the enzyme to UQ2 while the cyt bo3 is bound to the Ni-NTA column. The 
second method involves a quick exchange using enzyme already bound to the Ni-NTA 
column. The enzyme ~2.5 𝑢𝑀 (5 𝑛𝑚𝑜𝑙) was added to ~500 𝑢𝑙  resin. The enzyme-bound 
Ni-NTA resin was washed with 2 𝑚𝑙 of 1% DDM, 50 mM KPi buffer at pH 7 containing 
different concentrations of UQ2 and then immediately washed with about 15 mL of 
0.05% DDM, 50 mM KPi buffer at pH 8.3. The enzyme was then eluted using 150 mM 
imidazole, 0.05% DDM, 50 mM KPi buffer at pH 8.3. Following elution, the buffer was 
exchanged to eliminate the imidazole. 
 
3. Results 
UQ8 bound to the QH site is exchanged for exogenous UQ10 for cyt 
bo3 in the E. coli membrane 
To identify if exogenous quinone can bind at the QH site, we have fused liposomes 
containing UQ10 with E. coli membranes containing recombinant His-tagged cyt bo3. After 
purifying the enzyme, the amount of UQ8 that co-purifies is reduced and UQ10 is observed (Fig 
6.1). This result shows that the exogenous UQ10 can displace the endogenous UQ8 normally 
bound to the enzyme. This is not a quantitative experiment but shows at least that over the course 
of the several hours duration of this experiment the UQ8 must dissociate in order to be replaced 
by UQ10. The next set of experiments was designed to examine exchange of UQ8 bound to 
purified cyt bo3 placed in an artificial lipid bilayer. 
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Fig 6.1 The membrane fusion with liposomes including UQ10. MK7 was used for 
standard.  
 
Exchange of UQ8 bound to cyt bo3 in reconstituted 
proteoliposomes. 
1. Proteoliposomes without added UQ10: Purified cyt bo3 was 
reconstituted into unilamellar vesicles composed of phospholipids, DOPC. The enzyme 
was then solubilized using excess DDM detergent and re-isolated using a Ni-NTA 
column, followed by quinone extraction. The purpose of this experiment was to see if the 
bound UQ8 would dissociate into the phospholipid bilayer and be diluted out to such an 
extent that the equilibrium occupancy of UQ8 in the QH site would be diminished. This is 
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what was observed. Whereas the bound UQ8 has never been observed to dissociate from 
the purified cyt bo3 in DDM detergent, the UQ8 is dissociated once the enzyme is placed 
in a phospholipid bilayer. It was discovered during this experiment that at least 2 h 
incubation at room temperature with very high concentrations of DDM was required to 
solubilize the enzyme from the proteoliposomes. Control experiments showed that the 
bound UQ8 is not removed even by treatment of the enzyme with 10% DDM.  Hence, it 
is the placement within the lipid bilayer that facilitates dissociation of the long chain 
quinone. Under these conditions, 90% of the bound UQ8 was removed from the purified 
enzyme (see Fig 6.2)  
 
Fig 6.2 The exchange study using liposomes without substrates.  
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2. Reconstitution into proteoliposomes with UQ10. Next, we 
included UQ10 in the liposomes and measured the quinone content bound to the enzyme 
following re-purification. As shown in Fig 6.3, the bound quinone (UQ8) is nearly 
completely  (97%) replaced by UQ10. This clearly demonstrates that within a bilayer UQ8 
and UQ10 exchange occurs at the QH site.  
 
Fig 6.3 The exchange study using liposomes with UQ10 substrates. MK7 was used for 
standard. 
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proteoliposome as a monotopic membrane enzyme, and the enzyme reduces the UQ10 within the 
phospholipid bilayer (1% of the total lipid is UQ10). The reduced UQ10 can then be re-oxidized 
by the cyt bo3 within the bilayer. The reconstituted respiratory chain results in NADH oxidation 
and the reduction of O2 to water. Turnover of cyt bo3 was determined to be 500 e-/s, which is 
comparable to what has been measured using the short chain soluble UQ1H2 as the substrate in 
DDM detergent. Hence, the enzyme is perfectly capable of rapidly using the exogenously added 
UQ10H2 as a substrate within the bilayer.  
 
UQ8 bound to cyt bo3 can be readily exchanged for UQ2 in DDM 
detergent 
The data from the experiments described above demonstrate at least that UQ8 can be 
removed and replaced at least over the course of hours when the enzyme is placed in a lipid 
bilayer. Shorter times for the exchange could not be observed due to the technical issues of re-
solubilizing and isolating the enzyme from the proteoliposomes. Nevertheless, it is evident that 
the UQ8 might exchange more rapidly. This was tested by examining whether UQ2 could 
displace UQ8 from the QH site with the enzyme in DDM detergent. UQ2 is sufficiently water 
soluble so it can be readily added to detergent solution containing the enzyme, unlike the long 
chain UQ10. Although previous result showed that UQ8 remains bound the pure cyt bo3 in the 
presence of a large excess of UQ1, it was hoped that perhaps the more hydrophobic UQ2 might 
bind and displace UQ8 from the QH site. The fact that the mutations in the core residues at the QH 
site do not result in loss of the bound UQ8 suggests that the most important binding interactions 
are though the hydrophobic isoprenoid tail. The results show that just a 2 minute exposure of the 
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purified enzyme to a solution containing UQ2 results in nearly complete removal (>80%) of the 
UQ8 from the QH site. (Table 6.1) Repeating the same experiment with UQ1 does not result in 
removal of UQ8.   
 
UQ2 
(uM) 50 125 250 375 500 
< 2min 66 % ± 24.7 % 30 % 
24 % 
± 10.8 % 
26 % 
± 7.4 % 
18 % 
± 16.3 % 
30 min - - 20 % ± 2.8 % 
13 % 
± 2.8% - 
 
Table 6.1 Different UQ2 concentrations by incubation or flow through methods 
measuring the UQ8 content still bound.  
 
4. Discussion and conclusions 
The UQ8 that copurifies along with the enzyme in DDM detergent is “tightly bound” 
insofar as it does not dissociate from the enzyme even after considerable washing while bound to 
a column such as a Ni-NTA column. Hence, this bound has been considered to be a cofactor of 
the enzyme which does not dissociate significantly and, therefore, cannot serve as the substrate 
binding site which must exchange with the UQ8 in the quinone pool on a timescale of about 2 ms 
(steady state kcat of about 500 UQ8H2 per sec). The “tight binding” of UQ8 at this site is 
reinforced by the lack of any loss of the bound quinone even from mutants which alter the 
residues that are known to interact with the headgroup of the semiquinone species at the QH site 
[1, 19]. Moreover, this bound quinone does not dissociate when the enzyme is incubated with 
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large excess of exogenous UQ1 or UQ1H2 or in the presence of the inhibitor HQNO. These data 
present a strong case in support of a second “substrate binding site” denoted as the low affinity 
QL site.  
Most of the previously reported experiments involved characterizing the enzyme in DDM 
detergent. In the current work we have shown that the UQ8 bound at the QH site does dissociate 
much more readily when the enzyme is in a phospholipid bilayer, though this is still on an 
“hours” time scale. Furthermore, in detergent DDM, the bound UQ8 can be displaced by UQ2 
within a couple of minutes. Hence, at the very least the possibility must be considered that the 
quinone that is isolated bound at the QH site might, within the E. coli membrane, exchange 
rapidly with pool of UQ8 within the membrane bilayer.   
These data must now be considered in the light of the previously described experiments 
showing that 1) Despite an extensive search site-directed mutagenesis has not revealed a single 
residue outside of the QH site which indicate that it is part of the mysterious QL site; and 2) 
Mutations at D75, Q101 and F93 have been found that have properties expected for being at the 
substrate binding site, an increase in the KM of ubiquinol-1 and an increase in the Ki of the 
inhibitor HQNO.  
The simplest explanation is that there is only one quinone binding site which is defined 
by the residues at the QH site. So far, the implicated residues are R71, D75, F93, H98 and Q101.  
The extent to which these residues are important may depend on different interactions with the 
oxidized, fully reduced and semiquinone forms of the substrate. Postulating one site for quinone 
binding presents the problems that it has been well documented that the UQ1H2 acts as a 
substrate without displacing the bound UQ8 at what is now postulated to be the only quinone 
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binding site, and it has also been clearly shown that the inhibitor binds to the enzyme whether or 
not the UQ8 is bound to the QH site.  
How can two molecules interact simultaneously at the same site  (UQ1 vs UQ8 and 
HQNO vs UQ8)?  One possibility is that the “one site” is large enough to bind two molecules 
simultaneous, each relying on critical interactions with the same residues. The second possibility, 
which we favor, is that the binding free energy for quinones binding at the QH site is primarily 
from the hydrophobic isoprenoid tail and very little comes from interactions with the headgroup.  
In this way, the headgroup of UQ8 can be effectively dissociated from the region of the protein 
defined by the R71-Q101 set of residues, while at the same time remaining firmly bound via 
interactions with the isoprenoid side chain. The short tails on HQNO and UQ1 do not interfere 
with the interface that is most important for defining the affinity of UQ8 to the QH site, but the 
longer isoprenoid chain on UQ2 does bind to this same portion of the protein and can displace 
UQ8 even when the only place it can go is into the detergent micelle of DDM.  
We postulate there is only one binding site for the substrate UQ8H2 which we expect to 
be able to very rapidly dissociate when the enzyme is within the lipid bilayer of the E. coli 
membrane. Furthermore, we speculate that the headgroup of the natural substrate can be 
displaced by small quinone analogues (substrates or inhibitors) without displacing UQ8 when the 
enzyme is within a detergent micelle.   
Further work is needed to confirm elements of this model. 
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